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The mortality rate due to behavioral causes among veterans diagnosed with chronic post-
traumatic stress disorder (PTSD) is much higher than the rate found among the normal 
population.  In particular, veterans diagnosed with chronic PTSD die more frequently 
from conditions related to substance abuse, such as Hepatitis C, blood diseases, violence, 
aggression, and suicide. In addition, rates of behaviorally-related diseases such as 
obesity, diabetes, and heart disease are high among veterans diagnosed with chronic 
PTSD. These findings highlight a need to promote healthy behavioral practices among 
veterans diagnosed with PTSD. A manualized health promotion group treatment for 
veterans with PTSD was developed to target health risk behaviors prevalent among this 
population. The manual incorporates psychoeducation, motivational interviewing and the 
transtheoretical model to increase veterans’ awareness of their engagement in health risk 
behaviors and increase motivation for change. The meta-intention of the treatment 
protocol is to promote positive health practices and increase longevity and quality of life 
among this veteran population. This project focuses specifically on the development of 
the assessment strategy component of the group intervention. The assessment measures 
are interwoven into the group treatment and offer a comprehensive strategy for evaluating 








 Recent research has found that Vietnam veterans diagnosed with chronic combat-
related post-traumatic stress disorder (PTSD) die from high-risk behavioral causes, 
particularly those behaviors related to substance use, at a rate significantly greater than 
that of the normal population (Drescher, Rosen, Burling, & Foy, 2003).  A follow-up 
study by Schafer (2008) found that 45% of PTSD veteran deaths were due to behavioral 
causes. This is striking when compared with the mortality rate of 8% due to behavioral 
causes in the normal population. Of particular note were those deaths from Hepatitis C 
(21.5% vs. 0.2%), blood diseases (1.5% vs. 0.5%), and alcohol and drug use (24% vs. 
1%). An examination of these causes of death, as well as that which influences their 
acquisition and maintenance, suggests that the high rate of death due to behavioral causes 
seen in this population could be decreased with appropriate intervention.  
 The prevalence rates of Hepatitis C (HCV) and Human Immunodeficiency Virus 
(HIV) infection in the veteran population are significantly greater than that of the general 
population (Brau et al., 2002; Desai, Rosenheck, & Agnello, 2003). Estimates of HCV 
infection among veterans range from 7% - 44% (Cheung, 2000; Cheung, Hanson, 
Maganti, Keeffe, & Matsui, 2002; Desai et al.; Roselle, Danko, Kralovic, Simbarti, & 
Kizer, 2002). Estimates of HIV infection are also wide-ranging, with findings of positive 
HIV infection from 1.8% among treatment seeking homeless veterans (Cheung et al.) to 
as high as 37% among a random sample of veterans from the National Survey of 
Veterans (Hoff, Beam-Goulet, & Rosenheck, 1997).  Despite the wide range of HCV and 
HIV prevalence rates, the rate of HCV and HIV infection among veterans is considerably 





normal population are estimated to be 1.8% (Centers for Disease Control and Prevention, 
2006) and 0.6% for HIV (Unicef, n.d.). In addition, co-morbidity of the two diseases is 
common (Backus, Boothroyd, & Deyton, 2005; Cheung et al.). When examining veterans 
with PTSD, rates of HIV and HCV infection are even higher (Backus et al.; Hoff et al.; 
Lim, Cronkite, Goldstein, & Cheung, 2006; Nguyen et al., 2002).  
 The rates of comorbidity of substance use disorders (SUDs) and PTSD among 
veterans is also alarmingly high, with prevalence rates for comorbid SUDs ranging from 
37-92% in veterans with PTSD (Boudewyns, Albrecht, Talbert, & Hyer, 1991; Eisen et 
al., 2004; Roszell, McFall, & Malas, 1991) and comorbid PTSD rates of 46% among 
veterans with SUDs (McFall, Mackay, & Donovan, 1991). In fact, research has 
demonstrated that SUDs are the most frequently co-occurring disorders among veterans 
with PTSD (Faustman & White, 1989; Hryvniak, 1989). Although higher rates of alcohol 
abuse or dependence are found among veterans with PTSD, rates of drug abuse or 
dependence also remain very high (Hryvniak). Lifetime alcohol dependence rates range 
from 31-85% and lifetime drug dependence rates range from 4-60% (Eisen et al.; McFall, 
Mackay, & Donovan, 1992; Rozell et al.; Sutker, Uddo, Brailey, Vasterling, & Errera, 
1994).  
 Significant interrelationships can be found between HCV and HIV infection and 
substance use disorders. Those veterans who have a history of intravenous drug use or 
alcohol abuse and/or dependence are at risk for acquiring HCV and HIV (Backus et al., 
2005; Brau et al., 2002). Substance use may also serve to worsen HIV disease 
progression in veterans. Drinking is associated with poor virologic control, hepatic co-





decreased medication compliance in HIV positive veterans (Braithwaite et al., 2005). 
Those HCV positive veterans with substance use disorders or active psychiatric disorders 
are less likely to be eligible for treatment and experience more adverse effects resulting in 
premature discontinuation of treatment (Bini et al., 2005; Ho et al. 2001; Huckans, 
Blackwell, Harms, & Hauser, 2006). 
 Substance use has also been linked to other health risks, such as violence, 
suicidality, and chronic health problems in populations of veterans with PTSD (McFall et 
al., 1991; McFall, Fontana, Raskin, & Rosenheck, 1999; Prince, Risk, Haden, Lewis, & 
Spitaznagel, 2004; Tate, Norman, McQuaid, & Brown, 2007). Violence, suicide, and 
health problems are common causes of mortality among veterans diagnosed with PTSD 
with veterans with PTSD dying at higher rates from violence and suicide than the general 
population (suicide, 5% vs. 1%; homicide, 3% vs. 0.5%) and dying from heart disease at 
a rate of 20% (Schafer, 2008).   
 In addition to direct causes of mortality in the PTSD veteran population, there are 
indirect behavioral influences on mortality that also affect veteran quality of life. Sleep 
disturbances are cardinal features of PTSD. Sleep disturbances manifest as recurrent 
distressing dreams of the trauma and difficulty falling or staying asleep (Diagnostic and 
Statistical Manual of Mental Disorders-Fourth Edition Text Revision, 2000). Nightmares 
are the most common sleep disturbances among veterans with PTSD and occur at a rate 
of 65-94% (Jukic, Sumic, Brecic, & Muzinic-Masle, 1999; Leskin, Woodward, Young, & 
Sheikh, 2002). Other common sleep disturbances reported by veterans with PTSD with 
more frequency than by veterans without PTSD are insomnia, startle awakenings, 





Leskin et al.; Mellman, Kulick-Bell, Ashlock & Nolan, 1995). Sleep laboratory studies 
have also identified significantly decreased sleep efficiency and more microawakenings 
during sleep among veterans with PTSD when compared with normal controls (Husain et 
al.; Mellman et al.; Mellman, Nolan, Hebding, Kulick-Bell, & Dominguez, 1997).  
 Sleep disturbances are linked to strong emotional and physiological responses in 
veterans with PTSD. Trauma-related nightmares are accompanied by strong emotions 
that would have been appropriate during the traumatic event itself, such as rage, intense 
fear, or grief and may result in terror upon awakening (Ross, Ball, Sullivan, & Caroff, 
1989). Insomnia in veterans with PTSD is also characterized by high levels of anxiety, 
psychomotor activity, and fear (Inman, Silver, & Doghramji, 1990).  
Although there has been little research about the effect of sleep on high-risk 
health behaviors in veterans with PTSD, substance abuse/dependence literature suggests 
a link between sleep disturbance and substance use as well as substance use and PTSD. It 
is hypothesized that veterans with PTSD self-medicate with drugs and alcohol to decrease 
ideational reexperiencing and physiological arousal (McFall, et al. 1992; Roszell, et al., 
1991). The sleep disturbances found with high frequency among veterans with PTSD are 
associated with both reexperiencing and arousal symptoms and, thus, may be tied to 
increased distress and substance use in this population.  
The research demonstrates the substantial prevalence of sexually transmitted 
diseases, substance use, and sleep disturbances among veterans with PTSD and the 
extensive toll they take on the health and longevity of veterans. An intervention targeting 
these health risk behaviors and promoting behavioral change could lead to a decrease in 





health practices and quality of life among veterans diagnosed with PTSD.  In addition, a 
health promotion intervention could be used as a preventative measure to prevent the 
acquisition of health risk behaviors among those recently diagnosed with PTSD.  
 The primary motivation of this project was to develop a manualized health 
promotion group treatment promoting behavioral change of health risk behaviors 
commonly identified among veterans with PTSD. Research has shown that motivational 
interviewing is effective at reducing alcohol use, drug use, cigarette smoking, and risky 
sexual practices among adult populations (Ball et al., 2006; Bellack, Bennett, Gearson, 
Brown, & Yang, 2006; Butler et al., 1999; Carroll et al., 2005).  Although the research is 
limited among veteran populations, studies examining the efficacy of motivational 
interviewing in various behavioral domains suggest its efficacy extends to the veteran 
population (Davis, Baer, Saxon, & Kivlahan, 2003; Project MATCH Research Group, 
1997).  In light of the success of motivational interviewing in promoting behavioral 
change, this intervention incorporates motivational interviewing strategies to increase 
veterans’ awareness of their engagement in health risk behaviors and increase their 
motivation to change. To the developer’s knowledge, there is currently no standardized, 
motivational interviewing treatment protocol that focuses on addressing health risk 
behaviors in veterans diagnosed with PTSD.    
 This dissertation focuses specifically on the development of the assessment 
strategy which was designed to be an integral component of the motivational 
interviewing group intervention. The assessment strategy provides objective measures 
that allow the veterans to increase their awareness of their engagement in health risk 





assessments provide useful information to the group facilitators about the needs of the 
group members as well as the efficacy of the intervention. Furthermore, the assessment 
strategy provides a blueprint for empirical validation of the group treatment.  
Methods 
Purpose of the Resource 
Current research has demonstrated that mortality rates due to preventable 
behavioral causes are significantly higher in veterans with PTSD than in the general 
population. As such, a well-designed strategy to decrease health risk behaviors and 
promote positive health practices among veterans diagnosed with PTSD is needed. The 
purpose of this project was to develop a systematic approach to targeting those health risk 
behaviors that occur with increased frequency among veterans diagnosed with PTSD and 
lead to higher rates of mortality with the intention of promoting positive health practices 
and increasing longevity and quality of life among these veterans.  
This project proposed to create a group treatment comprised of a three-piece 
manual set that serves multiple functions. The manual set is intended to offer a systematic 
approach for the integration of health promotion practices in trauma treatment. It offers a 
well-designed approach for practitioners who wish to incorporate health promotion 
interventions into programs that provide services to veterans diagnosed with PTSD. 
Additionally, it integrates assessment measures into the treatment protocol that enhance 
the motivational interviewing treatment and allow for empirical investigation and 
validation of the efficacy of the group treatment. 
This project was founded on the Live Long and Prosper group, a group that was 





VAMC) residential PTSD treatment program. The Live Long and Prosper group was 
conceived by Kent Drescher, Ph.D. and Josef Ruzek, Ph.D. The development of the 
group was undertaken by Josef Ruzek, Ph.D. and, once outlined, was merged into an 
ongoing group designed and facilitated by Judith Faris, R.N.P. The materials developed 
by Ruzek and Faris served as the foundation for the development of this manual set. The 
three-component manual set is comprised of a facilitator’s manual, member workbook, 
and an assessment strategy and was collaboratively developed by three Pepperdine 
University doctoral candidates over a four-year period.  
Live Long and Prosper Group Development History 
 The inspiration for the original Live Long and Prosper group was rooted in the 
trauma literature and the research of providers working with combat veterans in a 
residential PTSD treatment program at the Menlo Park VAMC. This 60-day inpatient 
program offers group-based treatment with adjunctive individual psychotherapy as 
needed. Through research led by Kent Drescher, Ph.D. and David Foy, Ph.D. as well as 
reviews of the trauma literature, it became clear to clinicians and researchers at the Menlo 
Park VAMC that veterans in residential PTSD treatment were at increased risk of death 
from high-risk behaviors, including preventable diseases such as diabetes, cardiovascular 
disease, and Hepatitis C and from substance-related deaths such as accidents, suicides, 
and homicides. This realization led Kent Drescher, Ph.D. and Josef Ruzek, Ph.D. to 
create a high-risk behavior questionnaire and to develop a group designed to reduce 
mortality risk due to high-risk behaviors in this population. The issues of most concern 
for Drescher and Ruzek were aggression, gun ownership, aggressive driving, anger, poor 





smoking. Dr. Ruzek outlined the content for the group and ultimately merged the 
conceived high-risk behavior group with an on-going psychoeducational group run by 
Judith Faris, R.N.P. The intention of the new Live Long and Prosper group was to offer 
information and motivational strategies to aid veterans in making informed choices about 
their life, health, and futures.  
 The original Live Long and Prosper group ran for five years from 2002-2007. It 
was a 90-minute, once weekly group for between 20 and 40 group members. The group 
followed a rolling admissions model, which is the primary model employed at the Menlo 
Park VAMC residential PTSD treatment program. Due to the high levels of avoidance 
found among veterans with chronic PTSD, attendance at the group was mandatory. 
Assessment measures that evaluated engagement in high-risk behaviors were given at 
intake. Although the group was originally designed to have additional assessment 
measures completed at discharge and at four months post-treatment, these questionnaires 
were never created. In addition to the High-Risk Behaviors Questionnaire given at intake, 
veterans completed a gun ownership and a gun ownership stages of change questionnaire.  
 The idea to create the current proposed manualized health promotion group 
treatment came from inconsistencies that were identified in the content and facilitation of 
the original Live Long and Prosper group at the Menlo Park VAMC. The content, style, 
and format of the group varied widely depending on the individual facilitator. It was 
determined that content derived from thorough knowledge of the literature and use of 
validated motivational techniques could increase the group’s efficacy and relevance to 






 The project developers used existing group materials from the Live Long and 
Prosper group as the foundation for the development of the new health promotion group 
that incorporates the transtheoretical model and health risk behavioral frequency 
measurement into a formulized assessment strategy. The purpose of this dissertation was 
to develop the assessment strategy component of the group treatment.  The target 
audience for the assessment strategy is the group facilitator who is implementing the 
health promotion group intervention.  
Development of the Resource 
 The development of this manualized group protocol arose out of two pre-
established models of group treatment for veterans diagnosed with PTSD-Trauma Focus 
Group Therapy (Foy, Ruzek, Glynn, Riney, & Gusman, 2002) and the Trauma and 
Spirituality Group (Leoni, 2005; Romesser, 2005; Sornborger, 2005). Trauma Focus 
Group Therapy is a group treatment designed to enhance the ability of veterans with 
combat-related PTSD to manage their traumatic stress symptoms. The Trauma and 
Spirituality Group is designed to promote healthy spiritual practices among veterans with 
PTSD in order to improve coping abilities and enhance quality of life in this population. 
The decision to create a facilitator’s guide, member workbook, and assessment strategy 
for this health promotion group treatment for veterans diagnosed with PTSD was based 
on the structure of these pre-established group treatments.  
 The concept and content of the health promotion resource was built upon the 
original Live Long and Prosper group that was conducted at the Menlo Park VAMC. This 





use of psychoeducation as a means of promoting change in health risk behaviors. To 
build upon the intent of the original Live Long and Prosper group to motivate behavioral 
change, the developers of the current manual set decided to incorporate motivational 
interviewing into the treatment protocol. Current research has shown that motivational 
interviewing can be an effective method for promoting behavioral change across a wide-
variety of behavioral domains. This large body of research provides strong support for the 
efficacy of a health risk behavior intervention for veterans with PTSD constructed using 
the motivational interviewing treatment model.  
Division of the Literature 
 Current research has identified numerous health risk behaviors and health 
conditions that are prevalent among the veteran population. McFall and Cook (2000), in 
their review of the literature, found that smoking, alcohol use, obesity, and physical 
inactivity all presented significant health risk for veterans with PTSD.  Experts in the 
field of PTSD in veteran populations have further identified areas of needed health risk 
behavioral intervention through their clinical and research experiences. Based on the 
literature and the research and clinical expertise of expert practitioners, the developers of 
the current resource selected the health topics to be included in the current health 
promotion group. It was determined that the group would address aggression, diabetes, 
diet, gun safety, exercise, heart disease, obesity, sexually transmitted diseases, sleep, 
tobacco use, and substance abuse. In order to comprehensively explore the available 
research on the selected health topics, relevant empirical literature on diabetes, exercise, 
heart disease, sexually transmitted diseases, sleep, and substance abuse as well as 





reviewed by three doctoral candidates based on their thematic content. Relevant empirical 
literature reviews on aggression, diet, guns, obesity, and smoking previously completed 
by Pepperdine University doctoral students in a PTSD research lab were additionally 
included. For a comprehensive review of all health topics, refer to the other two 
components of this health promotion group, the Live Long and Prosper Facilitator’s 
Manual and Live Long and Prosper Member Workbook, as well as Pepperdine University 
dissertations by Carol Rotko, James M. Keener, Katherine Jakel, Lea Didion, Sarah Metz, 
and Edrick H. Dorian.   
Purpose and Content of the Assessment Strategy 
 The assessment strategy was designed to accompany the facilitator’s manual and 
the member workbook.  The assessment strategy comprehensively and systematically 
assesses veteran engagement in health risk behaviors and veteran motivation for change 
and is an integral component of the motivational interviewing protocol. Motivational 
interviewing seeks to “enhance intrinsic motivation for change by exploring and 
resolving ambivalence” (Miller & Rollnick, 2002, p. 25). Motivational interviewing 
exercises facilitate exploration of values and goals and the dissonance between these 
values and goals and current behavior. Assessment instruments strategically placed 
within the group protocol allow veterans to objectively assess their frequency of 
engagement in health risk behaviors and their current stage of change. They are 
encouraged to reflect upon the results of the behavioral frequency measures and explore 
how their current behavior correlates with personal values, interests, and goals. The 
objective results of these measures are thus integral to the process of developing 





their current level of desire to change, how their current stage of change may impact their 
goals and values, and assist veterans in monitoring any changes in their level of 
motivation throughout the intervention.   
 The assessment strategy also offers a way to systematically assess facilitator 
fidelity to the treatment protocol.  Collins et al. (2009) believe that facilitator adherence 
to the treatment protocol is key to establishing significant treatment effects to an 
intervention. In addition, facilitator adherence measures enable group facilitators to 
monitor their fidelity to the protocol and identify any obstacles to such adherence 
quickly.  In the Live Long and Prosper group, the facilitators will complete Facilitator’s 
Adherence Checklists following each session which may be used for empirical evaluation 
of the treatment protocol and self-monitoring by the group facilitators.  
 The assessment strategy provides a comprehensive blueprint for empirical 
validation of the treatment protocol. Pre- and post-intervention measures are included 
which allow for comparison of behavioral engagement and motivation for change pre- 
and post- intervention. In addition, pre- and post- session measures of motivation for 
change are included, which allow for validation of the efficacy of the intervention for 
each health risk behavior. In addition, adherence to the treatment protocol is measured 
following each session to ensure fidelity to the intervention. Included within the 
assessment strategy are schedules for test administration to facilitate ease of evaluation 
and promote consistency among empirical studies.  Alternative assessment schedules are 
offered for those sites unable to administer all measures.  
 The assessment strategy includes assessments in five domains: a) frequency of 





readiness to change pre- and post- intervention, c) veteran engagement in session specific 
health risk behaviors, d) veteran readiness to change heath risk behaviors pre- and post- 
session, and e) facilitator adherence to the treatment protocol. During the initial group 
session, all group participants are administered a comprehensive self-report measure 
assessing the frequency of their engagement in all relevant health risk behaviors and a 
readiness to change measure assessing their current stage of change for health related 
behaviors, attitudes, and practices. These measures will be re-administered at completion 
of the treatment to monitor changes in these domains. Each session, veterans will 
complete pre- and post-session readiness to change measures specifically related to the 
session content and session specific measures of behavioral frequency. Facilitators will 
complete assessments following each session that are designed to enhance facilitator 
adherence to the group treatment.   
Development Process 
 The assessment strategy was developed in conjunction with the facilitator’s 
manual and member’s workbook by three Pepperdine doctoral students over a four year 
period. The development of the assessment strategy and the manual set occurred in 
several distinct phases. First, the developers reviewed existing motivational interviewing 
group treatment protocols. The two most influential resources to the development of this 
manual set were Group Treatment for Substance Abuse: A Stages-of-Change Therapy 
Manual (Velasquez, Maurer, Crouch, & DiClemente, 2001) and Curriculum-Based 
Motivation Group: A Five Session Motivational Interviewing Group Intervention (Fields, 
2004). In addition to these two manuals, group developers also consulted Motivational 





Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with 
Alcohol Abuse and Dependence (Miller, Zweben, DiClimente, & Rychtarik, 1995), and 
Motivational Groups in Community Substance Abuse Programs (Ingersoll et al., 2002). 
These group treatment protocols were reviewed in order to generate ideas regarding the 
format and content of the manual set as well as offer insights into the use of motivational 
interviewing techniques into a group protocol.  
 The developers also received training in motivational interviewing though the 
Motivational Interviewing: Professional Training Series (Miller, Rollnick, & Moyers, 
1998)  as well as the seminal work Motivational Interviewing: Preparing People for 
Change, 2
nd
 Edition (Miller & Rollnick, 2002), Motivational Interviewing in Healthcare: 
Helping Patients Change Behavior (Rollnick, Miller & Butler, 2008), and Motivational 
Interviewing in the Treatment of Psychological Problems (Arkowitz, Westra, Miller, & 
Rollnick, 2007).  These sources informed the selection and application of motivational 
interviewing techniques into the group treatment protocol.  
Following review of the group treatment protocols and training in the 
motivational interviewing technique, the three developers began the co-creation of the 
facilitator’s manual. The facilitator’s manual was developed in ongoing collaboration 
between the three developers to ensure continuity of format, language, and content across 
the three components of the group treatment.  During the construction of the facilitator’s 
manual, the tenor of the intervention, structure of the psychoeducational and motivational 
interviewing components, and requirements of the member workbook and assessment 
strategy were defined. The content of the original Live Long and Prosper group informed 





participation is fostered through the use of open-ended questions regarding the health risk 
behaviors and subsequent provision of psychoeducation.  
As progress was made with the facilitator’s manual, feedback was gathered from 
Pepperdine graduate students in a PTSD research lab and experts in the field of veterans 
and trauma regarding the clarity, structure, content, and usability of the intervention. 
Their feedback was integrated into the manual set on an ongoing basis throughout its 
development.  
As the development of the facilitator’s manual approached completion, the 
developers were able to begin the creation of the assessment strategy and the member 
workbook. The exercises included in the member workbook stemmed directly from the 
interventions outlined in the facilitator’s manual and sought to maintain consistency of 
usage and ease of usability.  Workbook exercises designed to be used across sessions as 
well as session specific exercises were created.  The developers also included 
psychoeducation on each health risk behavior to help group members gain familiarity 
with each session topic as well as help them identify ways in which each health risk 
behavior may be impacting their lives. Finally, an introductory chapter introducing the 
group members to the motivational interviewing approach and the stages of change 
model and a concluding chapter of additional resources and positive behavioral 
substitutes were generated.  
In the development of the assessment strategy, assessment measures utilized in 
the existing group treatments previously mentioned were reviewed. In addition, 
behavioral frequency and stages of change measures available on the internet for diet, 





from numerous websites, specifically the National Institute of Health, Centers for Disease 
Control and Prevention, United States Department of Health and Human Services, 
American College of Sports Medicine, National Institute on Aging, United States 
Department of Agriculture, and the Cancer Prevention Research Center informed the 
assessment measures created by the developers. In addition, components of the High Risk 
Behavior Questionnaire developed by Kent Drescher, Ph.D. and Josef Ruzek, Ph.D., 
which was used as an assessment instrument used in the original Live Long and Prosper 
group, were adapted to inform session specific measures of behavioral frequency and 
motivation to change. Research was also undertaken to determine the most common 
measures of behavioral frequency used to assess substance use and smoking in research 
done within the veteran population. Those measures that appeared with the most 
frequency in the literature were identified, their ease of usability was ensured, and they 
were integrated into the assessment strategy.  In addition, the Facilitator’s Adherence 
Checklist was adapted from the Trauma and Spirituality Group (Romesser, 2005) to meet 
the needs of the current intervention.  
Measures of Behavioral Frequency 
 Pre-existing measures of the frequency of engagement in health risk behaviors as 
well as developer-created measures of behavioral engagement are included in the 
assessment strategy. Behavioral frequency measures are administered at the 
commencement of the group intervention, at completion of the group intervention, and 
during each session.  
 Health Behavior Frequency Measure.  The Health Behavior Frequency Measure 





engagement in health risk behaviors. This measure is administered to the group 
participants at the beginning of the first session of the health promotion group 
intervention and at the completion of the intervention. The HBFM assesses each domain 
of health risk behaviors that are a part of the group protocol; specifically, diet, exercise, 
sleep difficulties, risky sex behavior, aggressive acts, gun safety, substance use, and 
tobacco use. The measure incorporates questions regarding aggressive acts, gun 
ownership, and risky sex behavior from the High Risk Behavior Questionnaire (Ruzek et 
al., 2000), an unpublished measure used in the original Live Long and Prosper group. In 
addition, questions regarding substance use were informed by the structure of questions 
from the High Risk Behavior Questionnaire, Alcohol Use Disorders Identification Test 
(Babor, de la Fuente, Saunders, and Grant, 1992) and the Drug Use Questionnaire 
(Skinner, 1982), pre-existing measures incorporated into the substance use session.  
Assessment questions pertaining to diet, exercise, and sleep difficulties were informed by 
review of research in these areas.  
 The HBFM is a 21-question scale, with answers provided in a Yes-No format or 
on a Likert scale.  The measure allows for the qualitative analysis of veteran engagement 
in a variety of health risk behaviors that are found with great frequency among veterans 
diagnosed with PTSD and lead to increased mortality in this population. This measure is 
designed to provide information to the group facilitator about the frequency of veteran 
engagement in each behavioral domain at the onset of the group, which allows the 
facilitator to address the needs of individual veterans, as well as illuminate changes in 





measure is administered pre- and post-intervention, it allows for empirical validation of 
the intervention based on changes noted in veteran engagement in health risk behaviors. 
 Developer-created session specific measures of behavioral frequency. Session-
specific measures of behavioral frequency are administered during each session. These 
self-report instruments provide veterans with objective information about their level of 
engagement in health risk behaviors. These measures promote veteran awareness of their 
current level of behavioral engagement and provide information integral to the 
motivational interviewing exercises included in the group protocol.  
 Following an extensive review of measures assessing diet, heart disease, exercise, 
sleep, and safe sex behavior, the developers determined that the intervention would be 
best served by the creation of new measures specifically designed for the group 
intervention. The developer’s created five behavioral frequency measures designed to 
assess eating habits, risk for heart disease, exercise, sleep, and safe sex behavior. Each 
assessment measure was informed by the research and follows the recommendations of 
relevant groups dedicated to prevention of disease/health risk in these areas; specifically, 
the National Institute of Health, Centers for Disease Control and Prevention, United 
States Department of Agriculture, United States Department of Health and Human 
Services, American College of Sports Medicine, and the National Institute on Aging.  
 The self-report measures of behavioral frequency are presented in a variety of 
formats. Veterans are asked to respond using a Yes-No format, Likert scale, or by 
checking off individual boxes. Scoring is included for each measure and is designed to be 
user friendly. The scoring provides pertinent information that can be easily disseminated 





component is designed to elicit consideration by the veterans of their current level of 
engagement in health risk behaviors and offers suggestions for behavioral change.  
 Aggressive Behavior Questionnaire and Firearm Safety Questionnaire. The 
Aggressive Behavior Questionnaire and the Firearm Safety Questionnaire were created 
from the High-Risk Behavior Questionnaire (Ruzek et al., 2000). The High-Risk 
Behavior Questionnaire (HRBQ) is an unpublished instrument that assesses multiple 
domains of health-risk behaviors among the veteran population. It was originally 
designed to be administered to veterans as part of a comprehensive assessment package 
upon intake at the Menlo Park VAMC residential PTSD treatment program. The 
developers extracted and combined the questions measuring veteran engagement in 
aggressive behaviors and firearm safety from the HRBQ to create comprehensive 
measures.  
 The Aggressive Behavior Questionnaire is an 8-item self-report measure of 
aggressive behavior. Specifically, the measure assesses engagement in verbal threats, 
assault, property damage, and aggressive driving within the last year. Veterans are also 
asked to rate their frequency of engagement in any aggressive behavior in the last year on 
a Likert scale. The Firearm Safety Questionnaire is a 7-item self-report measure. It 
assesses whether firearms are kept according to National Rifle Association safety 
guidelines and personal risks factors for unsafe gun use, such as previous suicide attempt 
with a firearm or previous discharge of a weapon outside of military or law enforcement 
service.  Veterans are asked to answer questions about firearm safety in a Yes-No format. 
The developers decided to extend the time-frame of measurement from four months in 





Firearm Safety Questionnaire in order to gain a more comprehensive picture of veteran 
engagement in aggressive acts and account for possible time spent in treatment. The 
measures are administered concurrently during Session 7: Aggressive Behavior/Gun 
Safety.  
 Alcohol Use Disorders Identification Test. The Alcohol Use Disorders 
Identification Test (AUDIT; Babor, de la Fuente, Saunders, & Grant, 1992) is a 10-
question measure of alcohol use scored on a 5-point Likert scale. It was developed by the 
World Health Organization as a brief screening tool for excessive drinking. It is 
frequently used in the assessment of drinking behavior in research pertaining to veterans. 
The AUDIT provides an accurate risk assessment for hazardous or harmful alcohol use or 
alcohol dependence across cultures, gender, and age (Babor, Higgins-Biddle, Saunders, 
& Monteiro, 2001). Research has shown the AUDIT to have favorable sensitivity (.90) 
and lower but still acceptable specificity (.80) for current ICD-9 alcohol use disorders 
when using the cut-off score of 8 (Babor et al.), the cutoff score used in this assessment 
strategy. Research has also shown the AUDIT to have high internal consistency and high 
reliability (r=.86; Babor et al.). 
 The AUDIT was created for primary care workers to identify those who would 
benefit from reducing their level of alcohol consumption and to provide a framework for 
intervention among this population. These intentions are in line with the rationale for the 
current manual set targeting health risk behaviors and promoting motivation to change 
substance use habits. In the current group protocol, the AUDIT is administered during the 





 Drug Use Questionnaire, Short Form. The Drug Use Questionnaire, Short Form 
(DAST-10; Skinner, 1982) is a 10-item self-report instrument designed for brief clinical 
screening and treatment evaluation research to determine psychoactive drug abuse 
(Gavin, Ross & Skinner, 1989). Veterans are asked to note “yes” or “no” to questions 
regarding their engagement in drug use over the past 12 months. Research studies have 
found that the DAST, the original 28-item version, has high levels of internal consistency 
reliability (0.92), a largely unidimensional scale, and concurrent validity with frequency 
of drug use in the last 12 months (Skinner, 1982).  At a cut-off point between 5/6 and 
9/10, the DAST shows sensitivity between 96% to 78% and specificity between 79% and 
89% with overall accuracy of 85% (Gavin et al.). The DAST is also highly correlated 
with current (r=0.75) and lifetime (r=0.74) DSM-III drug diagnosis (Gavin et al.).  
 The DAST-10 is administered during the Substance Use session of the group 
intervention along with the AUDIT. The developers chose to administer the DAST-10, 
the short form of the DAST, rather than the DAST, a 28-item measure, to avoid fatiguing 
the group participants as multiple measures of behavioral frequency are administered 
during this session. In the current group protocol, the DAST-10 is administered with the 
intention of increasing veteran awareness of their level of drug use.  
 Fagerström Test for Nicotine Dependence. The Fagerström Test for Nicotine 
Dependence  (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991) is a 6-item 
self-report instrument designed to assess for level of nicotine dependence. Specifically, it 
assesses smoking frequency and habits. The FTND has been tested for reliability and 
validity among a psychiatric population and a population of veterans with PTSD 





on test-retest reliability (0.82) and was correlated at statistically significant levels with 
biological and psychological measures of dependence (0.40; Buckley et al.).   
 The FTND is administered to the group participants during the Tobacco Use 
session. It is designed to assist veterans in acknowledging their level of nicotine 
dependence and to promote critical thinking about their tobacco use.   
Stages of Change Measures 
 Developer-created stages of change measures are included in the assessment 
strategy. Stage of change is measured pre- and post- intervention as well as pre- and post- 
session.  The developers performed a comprehensive review of existing stages of change 
measures including the University of Rhode Island Change Assessment Scale 
(DiClemente & Hughes, 1990), stages of change measures utilized in research studies, 
stages of change measures included in other group protocols, and stages of change 
measures for health risk behaviors from the Cancer Prevention Research Center. As the 
stages of change measures found did not meet the exact needs of the current group 
protocol, the developers created new measures informed by their research and containing 
the most salient aspects of measurement of stages of change found across measures.  
 Health Risk Stages of Change measure. The pre- and post- intervention Health 
Risk Stages of Change measure was designed to assess the group participants’ current 
stage of change related to any behaviors in which they currently engage that may have a 
negative impact on their health. Although the group participants are encouraged to reflect 
upon those behaviors included in the group protocol, specific measures of stage of change 





 The measure assesses the group participants current stage of change by having the 
group participants first select one of six statements pertaining to their health related 
behaviors and then circle the stage of change the corresponds to the original statement 
selected. By separating the statement which best reflects their current health related 
behavior and the related stage of change, the developers hope to decrease judgment and 
promote honest disclosure of health risk behavior engagement.  
 The pre- and post- intervention Health Risk Stages of Change measure is designed  
to fulfill several functions. The pre- and post- intervention design offers a format for 
collecting empirical data about the efficacy of the group protocol to increase group 
participants’ motivation to change health risk behaviors over the course of the 
intervention. It also offers the group participants objective data on changes in their own 
motivation for change before and following the intervention. In addition, the pre- 
intervention measure is placed within the first session of the group protocol and is used to 
educate the group participants about the transtheoretical model and to familiarize them 
with the type of measure they will be asked to complete each week.  
 Session specific stages of change measures.  The group protocol includes seven 
session specific stages of change measures which are administered pre- and post- session. 
The group participant is asked to first select one of six statements pertaining to their 
session specific health related behaviors and then circle the stage of change that 
corresponds to the original statement selected. As with the pre- and post- intervention 
Health Risk Stages of Change measure, the session specific measures separate the 





the related stage of change to decrease judgment and promote honest disclosure of health 
risk behavior engagement.  
 The session specific stages of change measures are intended to perform multiple 
functions. First, they are designed to increase the group participants’ awareness of their 
current level of motivation for change, promote critical thinking about their own 
motivations, and illuminate any changes in motivation following the group session. In 
addition, the pre- and post- session design allows for empirical evaluation of the efficacy 
of the individual group sessions to motivate change in health risk behaviors.   
Faciltator’s Adherence Checklist 
 Following each session, the facilitator will complete a session-specific Faclitator’s 
Adherence Checklist. The Facilitator’s Adherence Checklist was adapted from the 
Adherence Checklist (Romesser, 2005) found in the Trauma and Spirituality Group 
protocol (Leoni, 2005; Romesser, 2005; Sornborger, 2005). In the Facilitator’s 
Adherence Checklist, the major components of each session are identified and the 
facilitator is asked to check off the completed components. Additional space is provided 
so the facilitator may note areas of difficulty, obstacles to completion, or issues of 
relevance for each session component.  The Facilitator’s Adherence Checklist allows for 
assessment of fidelity to the protocol. It also serves as a means of identifying problem 
areas, obstacles to successful session protocol completion, and areas for review when 







Veterans diagnosed with chronic PTSD are more likely to die, and to die at an 
earlier age, from behavioral causes than the general population. Many of the common 
sequelae of PTSD, such as substance abuse, aggression, and related behaviors such as 
risky sexual practices, contribute to these increased mortality rates. In addition, new 
research demonstrates that veterans with PTSD also suffer from increased rates of 
behaviorally-related chronic diseases such as diabetes, heart disease, and obesity. The 
Live Long and Prosper group treatment is designed to meet the needs of this population 
by decreasing veteran engagement in behaviors that have negative health impacts and to 
promote positive health practices among veterans diagnosed with chronic  PTSD.  The 
developers hope that this may reduce the risk of early mortality due to behavioral causes 
among this population.  
The majority of the research on which this group intervention is formulated is 
based on samples of older veterans, generally those who served during the Vietnam era. 
Among this group of veterans, health risk behaviors have often become chronic. For this 
older veteran population, the Live Long and Prosper group intervention offers the 
opportunity for older veterans to examine their level of their engagement in health risk 
behaviors, explore the reasoning behind their engagement in these behaviors, and begin 
to explore options for behavioral change. The intention of the intervention is to decrease 
veteran engagement in health risk behaviors and improve veteran quality of life.  
This group can also be used for those groups of veterans among whom health risk 
behaviors have yet to become chronic. Statistics demonstrate that 10 to 18% of military 
personnel are returning from the current military engagements in Afghanistan and Iraq 





the Live Long and Prosper group may be used preventatively. The group can be used to 
educate new veterans diagnosed with PTSD about the health risk behaviors associated 
with their mental disorder and mitigate their engagement in health risk behaviors prior to 
or at the early stages of their engagement in such behaviors. Early intervention may assist 
new veterans in maintaining positive health practices and increase their motivation to 
abstain from behaviors which may negatively impact their health and longevity.  
The current manual set is based on the Live Long and Prosper group which 
originated at the Menlo Park VAMC residential PTSD treatment program. As the 
Veterans Administration is now servicing larger numbers of veterans through outpatient 
services, the current group is designed to be implemented in an outpatient setting. To 
foster greater flexibility in an outpatient treatment setting, the group protocol can be 
implemented using either a cohort or a rolling enrollment model, with the understanding 
that each veteran should participate in an initial orientation session prior to joining the 
ongoing group sessions.  Despite being designed for an outpatient setting, the group can 
easily be implemented in a residential PTSD treatment program.  
Clinical Implications 
 The Live Long and Prosper group treatment is designed as an intervention for 
male veterans diagnosed with PTSD; however, it may be an effective intervention for 
both male and female veterans. The number of women who are exposed to military or 
combat-related trauma is increasing and, as such, the rates of PTSD in the female veteran 
population will also increase. It is likely that female veterans diagnosed with PTSD will 
engage in behaviors that risk their health and would benefit from a health promotion 





female veterans or female trauma survivors would be necessitated to ensure that health 
risk behaviors specific to women are adequately addressed in the group intervention and 
to determine the level of health risk to women of the behaviors already included in the 
Live Long and Prosper group.   
 Although this group intervention is specifically targeted at a veteran population, 
there may be other populations who have been exposed to high levels of trauma for 
which a manualized health promotion group intervention may be beneficial. Research 
among police officers in the United Kingdom found that prevalence rates of PTSD were 
six to seven times that of individuals in the community (Green, 2004). Also, a study of 
firefighters in Germany found high rates of PTSD among this population, with 18% of 
firefighters exhibiting PTSD symptoms (Wagner, Heinrichs, & Ehlert, 1998). Due to the 
high rates of PTSD found in these populations, it may be that a revised version of the 
Live Long and Prosper group treatment specifically focused on police officers or fire 
fighters would benefit these populations.  
Limitations 
 Although this intervention has sought to be comprehensive, several limitations 
exist which may affect its implementation or the efficacy of the intervention. Due to the 
high levels of avoidance found among veterans with chronic PTSD, the developers 
decided to maintain the expectation of the original inpatient Live Long and Prosper group 
of mandatory attendance. In an outpatient setting, mandatory attendance at the group may 
be difficult to sustain or enforce, particularly for those sessions in which group 
participants do not believe they are at risk. It becomes the responsibility of the group 





reinforce that the insights and experiences of each veteran, no matter what their stage of 
change for a particular health risk behavior, are useful for the group as a whole. The 
intervention also requires two facilitators who have received training in the motivation 
interviewing model, eight ninety-minute sessions, and the use of many workbook 
exercises and assessment measures. Limited resources in any of these areas may make it 
difficult to effectively implement the group intervention.  
 The Live Long and Prosper group is designed to increase motivation for change 
and promote engagement in positive health practices among veterans diagnosed with 
PTSD. Although strategies for implementing behavioral change are discussed in each 
session and examples of ways to change behaviors are provided in the member 
workbook, the intervention does not include follow-up behavior modification for those 
veterans who would like to change their behaviors. It is recommended that the group 
facilitators assess the motivation for change of each veteran and refer them to appropriate 
groups, short-term psychotherapy, or other appropriate avenues following the group 
intervention that will assist the veterans in following through on their desires for 
behavioral change.  
 The assessment strategy for the Live Long and Prosper group treatment is 
comprised of pre-existing as well as developer-created assessment instruments. The lack 
of validation for the developer created instruments is a limitation of the current group 
treatment and may create difficulties when attempting to study the efficacy of the current 
protocol with the intended population. In addition, there is currently no scoring system in 
place for the HBFM, an integral component of any research into the validity of the 





In addition, as of the publication of this dissertation, the intervention has not been 
validated with the population intended. Further validation of the instruments and pilot 
testing of the protocol itself are necessary to ensure its usability, user friendliness, and 
efficacy with the intended population.   
Future Research 
 Psychological assessments are an integral component of this motivational 
interviewing group treatment. They foster awareness and promote further evaluation of 
health risk behavior engagement and motivation for change among the group participants, 
provide information necessary to develop discrepancy and identify commitment to 
change, assist the group facilitators in monitoring the efficacy of the intervention, and 
offer a comprehensive method of empirically evaluating the protocol. As such, an 
important area for future research is the validation of the developer-created assessment 
instruments. In addition, a comprehensive scoring system for the HBFM needs to be 
developed which would provide quantitative results of veteran engagement in health risk 
behaviors.  
 To determine the ease of usability of the intervention, identify problem areas for 
improvement, and evaluate the efficacy of the group treatment, pilot testing of the Live 
Long and Prosper group intervention with outpatient veterans diagnosed with PTSD 
needs to be undertaken. The results of such testing would assist the developers in further 
refining the group treatment and improving its usability with the veteran population. In 
addition, due to the increase in female veterans diagnosed with PTSD who receive 





veterans diagnosed with PTSD be researched and the manual set be adapted for use with 
female as well as male veterans.  
 The Live Long and Prosper Health Promotion group treatment provides a 
systematic means to promote positive health practices among veterans and integrate 
health promotion into the treatment of veterans diagnosed with PTSD. It is a unique 
manual set that uses motivational interviewing and the transtheoretical model, already 
common treatment paradigms among substance abuse treatment programs for veterans, to 
fill a very relevant need in the VA system. The developers hope this protocol will initiate 
change among veterans diagnosed with PTSD who have poor health practices and 
prevent the acquisition of new negative health practices. This may, in the long run, 
increase veteran health, decrease treatment utilization, and increase longevity and quality 
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Narrative of the Empirical Literature 
A review of the literature was undertaken to establish a need-base for specific 
health risk behaviors to be included in the proposed “Live Long and Prosper” manualized 
group treatment for male combat veterans with PTSD. This review focused on sexually 
transmitted diseases, specifically Hepatitis C and Human Immunodeficiency Virus, 
substance use disorders, and sleep disturbances. Several computer databases were used to 
locate relevant literature (PsychINFO, ProQuest databases, PubMed, and Dissertation 
Abstracts) using specific search terms (Hepatitis C, HIV, combat veterans, PTSD, STDs, 
substance abuse, sleep disorders, high-risk behaviors) as well as their different variations 
(e.g. PTSD, posttraumatic stress disorder, alcohol abuse, SUD, sleep problems). Twenty-
six empirical studies comprise the literature review for STDs, 20 for SUDs, and 16 for 
sleep disturbances. The selection criteria limited the articles to quantitative studies 
comprised of 30 or more male veterans with PTSD. However, the number of participants 
required for sleep laboratory and psychopharmacological studies was reduced to 15 as the 
nature of the research methodologies limits the number of potential participants. In 
addition, due to the paucity of research in the area of HCV in veterans with PTSD, the 
STD literature review was expanded to include all veterans. The literature supports the 
assertion that STDs, SUDs, and sleep disturbances pose substantial health-related risks 
for veterans.  
Hepatitis C and Human Immunodeficiency Virus 
 The literature demonstrates significantly higher rates of sexually transmitted 
diseases among the veteran population than the normal population. Prevalence rates for 





Huckans, Blackwell, Harms, & Hauser, 2006; Roselle, Danko, Dralovic, Simbarti & 
Kizer, 2002) to 42% - 44% among homeless veterans (Cheung, Hanson, Maganti, Keeffe, 
& Matsui, 2002; Desai, Rosenheck, & Agnello, 2003). In a study of 168 Department of 
Veterans Affairs sites from 1991-1994, the rates of HCV-positivity increased 285% while 
the sites only experienced a 5% increase in patients during the same time period (Roselle, 
Mendenhall, & Danko, 1997). HCV prevalence rates among veterans are particularly 
striking when compared to rates of HCV in active duty military personnel, which are less 
than or equal to the prevalence rates for HCV found in the normal population (Hyams et 
al., 2001). Prevalence rates of HIV infection are also high with estimates of up to 37% 
among a national survey of veterans (Hoff, Beam-Goulet, & Rosenheck, 1997). These 
prevalence rates suggest that HCV and HIV are overrepresented in the veteran 
population.  
A relationship between HCV and HIV was also demonstrated in the literature. 
When HCV/HIV co-morbidity was examined, 2% of HCV-positive veterans were also 
HIV-positive (Cheung et al., 2002) and 37% of HIV-positive veterans were also HCV-
positive (Backus, Boothroyd, & Deyton, 2005). A study of homeless veterans (Cheung et 
al.) found that among those veterans who had multiple disease infections including HIV, 
Hepatitis B, and tuberculosis, HCV was found in each case.  
 Although the rates of HCV and HIV are high for the entire veteran population, 
they present with greater frequency in those veterans with mental illness (Backus et al., 
2005; Nguyen et al., 2002; Yovtcheva, Rifai, Moles, & Van der Linden, 2001). In 
particular, veterans with PTSD are more likely to be HCV and HIV positive (Hoff et al., 





ranging from 20 - 43% among HCV-positive veterans (El-Serag, Kunkik, Richardson, & 
Rabeneck, 2002; Lehman, & Cheung, 2002; Nguyen et al.). These findings correspond to 
the significant relationship found between service during the Vietnam era and HCV and 
HIV infection (Backus et al.; Bini et al., 2005; Desai et al., 2003; Nguyen et al.; Roselle 
et al., 2002; Seal et al., 2007), suggesting that Vietnam-era combat veterans are at 
particular risk of acquiring both HCV and HIV.   
 An examination of the risk factors for HCV and HIV acquisition in veterans 
suggests relationships between these STDs and specific health risk behaviors including 
intravenous drug use (IVDU) and alcohol abuse. Significant associations were found 
between HCV and HIV positivity and IVDU (Brau et al., 2002; Cheung, 2000; Cheung et 
al., 2002; Conigliaro, Gordon, McGinnis, Rabeneck, & Justice, 2003; Desai et al., 2003). 
Those veterans who were HCV-positive were more likely to report IVDU (Backus et al., 
2005; Brau et al.; Cheung; Cheung et al.) and those with a lifetime history of drug use 
were 5-7 times more likely to be HCV-positive than those without such history (Desai et 
al.; El Serag et al., 2002). HCV-positive veterans were also more likely to report alcohol 
abuse (Backus et al.; Brau et al.) and current hazardous drinking was common among 
HIV-positive veterans (Conigliaro et al.). Rates of alcohol abuse and dependence range 
between 27% - 86% among HCV-positive veterans (Brau et al.; El-Serag et al.; Lehman 
et al., 2002; Lim et al., 2006; Nguyen et al., 2002; Yovtcheva et al., 2001) and up to 36% 
among HIV-positive veterans (Conigliaro et al.). Those veterans with substance use 
disorders were significantly more likely to test positive for HCV, HIV, and HCV/HIV 





substance use disorders were found, veterans were 11.5 times more likely to be HIV 
positive (Hoff, 1997).  
 High-risk sexual behavior is also a risk factor for HCV and HIV infection (Cook 
et al., 2006; Seal et al., 2007).  Alcohol and drug use were related to risky sex behavior in 
HIV-positive veterans, with intoxication before intercourse positively related to 
inconsistent condom use (Cook et al., 2006). Ganguly, Lenox, Quiroz, and Sinnott (2002) 
also found that a majority of veterans did not use condoms despite having sexual 
relationships with multiple partners. HIV transmission knowledge was also a concern as 
veterans with PTSD demonstrated inaccurate HIV transmission knowledge (Strauss, 
Bosworth, Stechuchak, Meador, & Butterfield, 2006). 
 Substance abuse is not only a risk factor for HCV and HIV disease acquisition, 
but it impacts HIV disease progression, medication compliance, HCV treatment 
candidacy and treatment completion, and mortality in veteran populations (Bini et al., 
2005; Braithwaite et al., 2005; Conigliaro et al., 2003; Huckans et al., 2006; Johnson, 
Finney & Moss, 2005; Seal et al., 2007).  Conigliaro et al. found that drinking may be 
associated with poor virologic control, hepatic co-morbidity, and anemia among HIV 
positive veterans. Decreased virologic control may be related to the temporal and dose 
response relationship of drinking behavior to poor medication adherence found among 
HIV positive veterans. Braithwaite et al. found that consumption of alcohol was related to 
decreased medication adherence for two days following drinking and was particularly 
poor when quantities of alcohol that met criteria for hazardous drinking were consumed.   
Treatment candidacy and completion is also impacted by substance use among 





likely to be eligible for HCV treatment (Bini et al., 2005; Huckans et al., 2006) and 
experienced more adverse events resulting in discontinuation of therapy (Ho et al., 2001). 
Seal et al. (2007) found no association between IVDU and treatment candidacy, however 
their findings did support the inverse relationship between alcohol consumption and 
treatment candidacy and treatment completion found in other studies. Finally, HIV/AIDS 
status has been found to predict mortality in substance abusing veterans (Johnson et al., 
2005).  
 In addition to those with substance use disorders, those with active psychiatric 
disorders were less likely to be eligible for HCV treatment (Bini et al., 2005; Huckans et 
al., 2006). The rates of active psychiatric disorders and/or recent substance use were 
between 33% - 73% among HCV positive veterans (Backus et al., 2005; El-Serag et al., 
2002; Lehman et al., 2002), suggesting that a large portion of the infected veteran 
population, including those with chronic PTSD, may not be eligible for treatment for 
HCV infection. 
 The literature has shown alarmingly high rates of HCV and HIV infection among 
veterans, with veterans with PTSD at particular risk for infection. Substance abuse or 
dependence is the number one risk factor for HCV and HIV infection and also negatively 
impacts disease progression, treatment, and mortality among HCV and HIV positive 
veterans. HCV and HIV infection, as well as comorbid substance use, poses a substantial 
health risk for veterans with PTSD. These findings suggest that a treatment that focuses 
on HCV and HIV disease acquisition, as well as comorbid substance use, could impact 





Substance Use Disorders 
Substance use disorders are the most frequent co-occurring diagnoses among 
veterans with PTSD (Faustman & White, 1989; Hryvniak, 1989; Sutker, Uddo, Brailey, 
Vasterling, & Errera, 1994). SUDs were found at a rate of 91% among inpatient veterans 
with PTSD (Boudewyns, Albrecht, Talbert, & Hyer, 1991; Boudewyns, Woods, Hyer, & 
Albrecht, 1991) and at a rate of 47-68% among treatment-seeking veterans with PTSD 
(Davidson, Kudler, Saunders, & Smith, 1990). In a representative national sample of 
veterans with PTSD, 75% had comorbid SUDs (Kulka, Schlenger, & Fairbank, 1990). 
When substance abusing or dependent veteran populations were examined, 46% of 
veterans with SUDs had a co-occurring diagnosis of PTSD (McFall, Mackay, & 
Donovan, 1991). In addition, substance-abusing veterans with PTSD had more severe 
drug and alcohol problems than substance abusing veterans without PTSD (McFall, 
Mackay, & Donovan, 1992).   
When alcohol and drug use are examined separately, higher rates of alcohol abuse 
or dependence were found among veterans with PTSD than drug abuse or dependence 
(Hryvniak, 1989). Lifetime alcohol dependence rates among veterans with PTSD range 
from 31-85% (Eisen et al., 2004; Kulka et al., 1990; Rozell, McFall, & Malas, 1991; 
Sutker et al., 1994), which far exceeds lifetime prevalence rates for alcohol dependence 
in the general male population. Rates of current alcohol abuse or dependence among 
veterans with PTSD range from 4-68% (Eisen et al.; Kulka et al.; Rozell et al.; Sutker et 
al.). Although occurring with less frequency, rates of drug abuse or dependence among 
PTSD veterans remained high. Lifetime drug dependence rates among veterans with 





Sutker et al.) and rates of current drug abuse or dependence range between 1-10% (Eisen 
et al.; McFall et al.; Rozell et al.; Sutker et al.). These studies demonstrate that both 
alcohol and drug abuse and dependence are found with distressing frequency among 
veterans with PTSD.  
The high comorbidity rate of PTSD and SUDs among veterans led researchers to 
hypothesize about the etiological relationship between the two disorders in this 
population. The literature supports a functional relationship between substance use and 
PTSD. It suggests that veterans abuse alcohol and drugs to self-medicate against PTSD 
symptoms (Vaidya & Garfield, 2003). One study found that 37% of veterans with PTSD 
reported using alcohol or drugs to avoid dealing with trauma memories or feelings 
associated with the trauma (Roszell et al., 1991). Similarly, McFall et al. (1992) found a 
positive relationship between alcohol and drug abuse and the occurrence of ideational 
reexperiencing, physiological arousal, and avoidance/numbing among PTSD veterans. 
Veterans with PTSD have also reported that alcohol, heroin, benzodiazepines, and 
marijuana served as effective mediators of PTSD symptoms (Bremner, Southwick, 
Darnell, & Charney, 1996).  Post-treatment studies also support the self-medication 
hypothesis. Steindl, Yound, Creamer, and Crompton (2003) found that drinking status 
was significantly associated with PTSD symptoms at follow-up, with unchanged 
hazardous drinkers experiencing more severe avoidance, numbing and arousal symptoms 
when compared to new low-risk drinkers. Increased psychiatric symptoms were also 
significantly greater prior to relapse among those with trauma histories (Norman, Tate, 





Substance abuse in veterans with PTSD has been linked to several health risk 
behaviors including violence, suicidality, and chronic health problems. In addition, 
substance use is linked to the acquisition of STDs in veterans and has negative 
implications for treatment and disease progression in HIV and HCV positive veterans 
(see Hepatitis C and Human Immunodeficiency Virus for review of the literature). 
Substance abuse was found to contribute significantly to the variance in violence levels 
among treatment seeking PTSD veterans (McFall, Fontana, Raskind, & Rosenheck, 
1999). PTSD also contributed to the prediction of difficulty controlling violent tendencies 
in veterans seeking substance use treatment (McFall et al., 1991). Among substance using 
veterans, PTSD was found to contribute significantly to suicidal thoughts (McFall et al., 
1991) and remission from suicidality occurred more slowly in veterans with comorbid 
PTSD and drug dependence (Prince, Risk, Haden, Lewis, & Spitznagel, 2004). Veterans 
with comorbid substance use disorders and PTSD were also found to have increased rates 
of chronic health problems, such as musculoskeletal problems (e.g. joint problems), 
gastrointestinal problems, and cardiovascular problems than those with substance use 
disorders only (Tate, Norman, McQuaid, & Brown, 2007).  
The extraordinary prevalence rates of SUDs among veterans with PTSD and the 
health risk behaviors that are associated with this comorbid pattern support the need for a 
program to target substance use and its relationship to health risk behaviors in veterans 
with PTSD. Additional literature suggests that it may be important to offer treatment to 
non-combat veterans with PTSD as well. Mixed findings regarding the relationship 
between substance use disorders and combat experience suggest that both combat and 





study of non-combat Persian Gulf veterans exposed to trauma, Sutker et al. (1994) found 
that the first incidence of alcohol or drug dependence among recent war-zone returnees 
was 11%, compared with 0% in those who remained stateside. Also, postmilitary factors 
have been found to contribute significantly to the variance in alcohol and drug abuse 
disorders over and above premilitary and military factors in a population of male veterans 
with PTSD (Green, Grace, Lindy, Gleser, & Leonard, 1990).  These findings suggest that 
a health promotion group that targets substance use may be useful for veterans with both 
combat-related and non-combat-related PTSD.  
Sleep Disturbances 
 Sleep disturbances are found with high frequency among veterans with PTSD 
(Roszell, McFall, & Malas, 1991). Commonly experienced sleep problems include 
combat and non-combat related nightmares, insomnia, nonrestorative sleep, decreased 
sleep quantity, and startle or panic-like awakenings. Nightmares are the most prominent 
sleep disturbance found in veterans with PTSD and are reported with great frequency by 
this population (Neylan et al.,1998). Frequency rates of nightmares among combat 
veterans with PTSD range between 65-94% (Jukic, 1999; Leskin, Woodward, Yound, & 
Sheikh, 2002). Forty percent of veterans with PTSD report avoiding sleep because of the 
anticipation of troubling thoughts or dreams (Roszell et al.).  
 The prevalence rates of other sleep disorders in the PTSD veteran population are 
also high, with 80-100% of a national sample of PTSD veterans reporting insomnia and 
61-88% reporting an exaggerated startle response, which may lead to startle or panic-like 
awakenings (Leskin et al., 2002). In addition, 59-73% of veterans with PTSD report 





higher frequency of body movement and periodic limb movement during sleep among 
veterans with PTSD when compared to veterans without PTSD (Husain, Miller, & 
Carwile, 2001; Mellman et al.).  
 Sleep laboratory studies have been able to provide objective information about 
sleep disturbances in veterans with PTSD. Sleep efficiency, or the proportion of actual 
sleep to potential sleep, has been shown to be significantly decreased in veterans with 
PTSD (Husain et al., 2001; Mellman et al., 1995; Mellman, 1997), confirming veteran 
self-report data. Veterans with PTSD appear to spend significantly more time awake 
during sleep and experience more microawakenings than healthy male controls (Mellman 
et al.). REM sleep is also affected in PTSD veterans, although the direction of the 
findings is mixed. Engdahl, Eberly, Hurwitz, Mahowald, and Blake (2001) found that 
PTSD veterans spent more time in REM sleep and had fewer arousals from nonREM 
sleep than veterans without PTSD. However, laboratory studies by Mellman (1995, 1997) 
found that PTSD veterans experienced decreased time in REM sleep and increased wake-
during-sleep when compared with other clinical or non-clinical samples. 
 A large proportion of the research on sleep disorders relies on self-report findings. 
The nightmares reported by PTSD veterans are distinguished from those of veterans 
without PTSD by their fright content (Husain et al., 2001) and are highly associated with 
combat experience (Neylan et al., 1998). Veterans with PTSD often recall more dreams 
and have difficulty returning to sleep after having a nightmare (Inman, 1990). In addition 
to nightmares, insomnia in veterans with PTSD is characterized by high levels of anxiety, 
high levels of psychomotor activity, and fear (Inman). PTSD veterans report fear of going 





Middle of the night awakening and subsequent decrease in hours of sleep are associated 
with combat nightmares, movement during sleep, and startle or panic-like awakenings 
(Mellman et al., 1995; Woodward, Arsenault, Murray, & Bliwise, 2000).  
 The nightmares, insomnia, and nonrestorative sleep that are associated with PTSD 
in veterans represent a risk to their global clinical status. This is demonstrated by the 
profusion of psychopharmacological studies aimed at reducing overall PTSD symptom 
presentation by decreasing the frequency of trauma-related nightmares and sleep latency, 
and increasing sleep efficiency (Aukst-Margetic, Margetic, Tosic, & Bilic-Prcic, 2004; 
David, De Faria, & Mellman, 2006; Raskind, Peskind, Hoff, & Hart, 2007; Stein, Kline, 
& Matloff, 2002). The pharmaceuticals Prazosin, Levomepraomazine, and Risperidone 
are reported to significantly decrease distressing dreams, increase sleep duration, and 
decrease nighttime awakenings in veterans with PTSD (Aukst-Margetic et al.; David et 
al.; Raskind et al.), while Olanzapine was not found to be superior to treatment with a 
placebo when clinical status was considered (Stein et al.). 
Sleep disturbances are common among veterans with PTSD. Trauma-related 
nightmares are the most prominent sleep disturbance, however high rates of insomnia, 
nighttime awakenings, and nonrestorative sleep are also found. Sleep efficiency is 
significantly decreased in this population and is characterized by increased sleep latency 
and increased microawakenings. Many of these sleep disturbances are characterized by 
fear related to high levels of anxiety. Current research is focused on 






 A comprehensive review of the literature focusing on sexually transmitted 
diseases, substance abuse disorders, and sleep disturbances among veterans and veterans 
with PTSD has shown that these problems represent significant health risks for veterans 
with PTSD. Not only do they occur with high frequency, but they impact multiple areas 
of life including disease progression, treatment, health, aggression, and sucidality. A 
treatment protocol designed to decrease incidence of these health risk behaviors in 
veterans with PTSD may serve to increase longevity and quality of life in this veteran 
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Sexually Transmitted  Diseases Literature Table   n=26 
AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Backus, L. I., 
Boothroyd, D., & 
Deyton, L. R. 
2005 
HIV, Hepatitis C, and 
HIV/Hepatitis C Virus 
Co-infection in 
Vulnerable Populations 
n=18,349 veterans in the 
VA Immunology Case 
Registry who received 
care in the VA in 2002 
who had an interpretable 
HCV result  
Enzyme immunoassay 
antibody test results 
Retrospective review. ICD-9 
codes used to determine 
psychiatric diagnoses. 
Medical diagnoses also 
discerned by prescribed 
medication.   
 
Analyses: Pearson chi-square 
test, Wilcoxon rank-sum test 
 37% HCV seropositive 
 HCV seropositive veterans were more 
likely to report IVDU, alcohol abuse, 
substance abuse, and to have been 
diagnosed with mental illness. 
 Rate of mental health illness was very 
high in both groups (63.1% HIV, 
76.1% HIV/HCV).  
 Those with HIV/HCV were less likely 
to develop AIDS but more likely to 
die.  
Bini, E. J.,  Brau, 
N.,  Currie, S.,  
Shen, H.,  Anand, 
B. S.,  Hu, K. , et 
al. 2005 
Prospective Multicenter 
Study of Eligibility for 
Antiviral Therapy 
Among 4,804 US 
Veterans with Chronic 
Hepatitis C Virus 
Infection 
n=4,084 treatment-
seeking veterans who had 
a positive HCV antibody 
test at 24 VA Medical 
Centers 
COBAS Amplicor HCV 
Monitor Test version 2.0 
or the COBAS Amplicor 
HCV Test version 2.0 to 
test HCV RNA 
Interviewed to obtain 
demographic, clinical and 
risk factor information.  
Evaluated for HCV therapy 
using standardized criteria. 
Eligible veterans were 
treated with Rebetron for up 
to 24 or 48 weeks.  
 
Analyses: t-tests or 
Wilcoxon, chi-square test, 
regression models, odds 
ratios 
 32.2% of candidates were eligible for 
HCV treatment. The most common 
reasons for exclusion were on-going or 
recent substance abuse, active 
psychiatric disease, and comorbid 
medical disease.  
 Of those eligible for treatment, 76.2% 
agreed to receive treatment. 
 Factors associated with increased odds 
of declining therapy: 50 years of age or 
older, having more than 50 lifetime 
sexual partners. 
Braithwaite, R. S., 
McGinnis, K. A., 
Conigliaro, J.,  
Maisto, S. A., 
Crystal, S., Day, 
N., et al. 2005 





Among Veterans in Care 
n=2,352 HIV+ and 
matched HIV- veterans 
participating in the 
Veterans Aging Cohort 
Study; n=99 veterans who 
reported widely varying 
levels of alcohol 
consumption during the 
30-day period for dose-
response analyses selected 
out from larger sample for 
analyses 
Alcohol Timeline Follow 
Back; Timeline Follow 
Back Modified for 
Adherence; PHQ-9 for 
depression  
Cross-sectional study. 
Telephone surveyed for 





 A strong temporal and dose-response 
association was found between alcohol 
consumption and poor adherence and 
dose-response.  
 Consumption on a particular day was 
associated with decreased adherence to 
medication on that day and for two 
days immediately following that day.  
 A relationship between poor adherence 
and quantity of alcohol consumed was 
found, with particularly poor adherence 
when quantities of alcohol were 
consumed that met the criteria for 
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Brau, N., Bini, E. 
J., Shahidi, A., 
Aytaman, A. l., 
Xiao, P., Stancic, 
S., et al. 2002 
Prevalence of Hepatitis C 
and Coinfection With 
HIV Among United 
States Veterans in the 




undergoing phlebotomy at 
six Veterans Affairs 
Medical Centers in the 
NYC metropolitan area  
Third generation enzyme 
immunoassay; HCV 
RNA and HCV 
recombinant immunoblat 
assay antibody testing; 




for demographics and 
HCV risk factors 
1-day cross-sectional survey. 
All veterans having blood 
drawn on a particular day 
were asked to complete the 
questionnaire and have blood 
additionally analyzed for 
HCV.  
 
Analyses: Student’s t test, 
chi-square, regression 
analyses 
 10.6% HCV positivity  
 Independent risk factors for HCV 
infection:  injection drug use, blood 
exposure during combat, alcohol 
abuse, and service during Vietnam.  
 53.4% reported alcohol abuse. 
 24.8% HCV/HIV co-infection  
 Independent risk factor for HIV 
coinfection: age (<50 years). 
 Rates of anti-HCV positive were 
significantly higher than that of the 
general population.  
 56% of HCV-positive patients were 
unaware of their diagnosis.   
Cheung, R. C. 
2000 
Epidemiology of 
Hepatitis C Virus 
Infection in American 
Veterans 
n=8,558 veterans who 
were tested for anti-HCV 
serology 




Hepatitis B surface 





completed by primary or 
referring physician 
Risk factors for HCV were 
reported by primary or 




 35% HCV prevalence  
 Authors estimate a true prevalence rate 
of 7-35% . 
 More than 80% of those HCV positive 
were between the ages of 41 and 60 
with only 0.2% between the ages of 21 
and 3.  
 IVDU was the most common risk 
factor (81%).  
Cheung, R. C., 
Hanson, A. K., 
Maganti, K.,  
Keeffe, E. B., & 
Matsui, S. M. 
2002 
Viral Hepatitis and Other 
Infectious Diseases in a 
Homeless Population 
n=597 homeless veterans 




Tuberculin skin test and 




using commercial kits for 
antibody to HCV; 
Hepatitis B surface 
antigen for chronic HBV 
infection; Hepatitis B 
surface antigen for past 
HBV infection; Antibody 
to HIV 1/2.  
Interview conducted by 
experienced interviewers and 
adapted from an established 
instrument to confirm self-




 Prevalence rates: HCV (41.7%), PPD 
(20.6%), HIV (1.8%), HBsAg (1.2%)  
 52.6% tested positive for one of four 
diseases with majority presenting with 
only one disease.  
 In cases with multiple disease 
presentations, HCV was found in each 
case.  
 IVDU was significantly associated 
with HCV infection, past HBV 
infection and positive PPD.  
 HCV was an independent risk factor 
for HBV infection.  
 Anti-HBV positivity and IVDU were 






AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Conigliaro, J., 
Gordon, A. J., 
McGinnis, K. A., 
Rabeneck, L., & 
Justice, A., 2003 
How Harmful Is 
Hazardous Alcohol Use 
and Abuse in HIV 
Infection: Do Health Care 
Providers Know Who Is 
at Risk 
n=881 treatment-seeking 
veterans with HIV 
infection from the 
Veterans Aging Cohort 3-
Site Study 
AUDIT 
Retrospective chart review 
and longitudinal study. ICD-
9 codes for diagnoses of 
alcohol abuse of dependence 
and laboratory variables 
collected from VA electronic 
medical records. Surveyed 
clients at baseline and 12-
month follow up. Health care 
providers were surveyed for 
their perception of veteran 
alcohol use.  
 
Analyses: chi-square, t-tests, 
regression analyses 
 36% of HIV+ veterans reported current 
hazardous drinking (AUDIT score of 
>= 8 or binge drinking in the past 12 
months) . 
 Hazardous drinking was associated 
with younger age and current drug use.  
 27% had at least 1 ICD-9 alcohol-
related diagnosis in the last 5 years.   
 ICD-9 alcohol-related diagnosis was 
associated with higher transaminase 
levels, anemia and elevated mean 
corpuscular volume.  
 Health care providers’ report of current 
drinking and current hazardous 
drinking were poor.  
Cook, R. L., 
McGinnis, K. A., 
Kraemer, K. L., 
Gordon, A. J., 
Conigliaro, J. 
Maisto, S. A., et 
al. 2006 
Intoxication Before 
Intercourse and Risky 
Sexual Behavior in Male 




n=1,719 veterans enrolled 
in the Veterans Aging 
Cohort 5-Site Feasibility 





sexual behaviors, drug 
and alcohol use; AUDIT; 
DAST 
Cross-sectional study. Open-
ended questions assessing 
sexual behaviors and 
condom use.  
 
Analyses: chi square, 
regression analyses 
 1 in 10 veterans regardless of HIV 
status reported 2 or more sexual 
partners with inconsistent condom use 
in the past year.   
 Intoxication before intercourse was 
significantly associated with 
inconsistent condom  use, 2 or more 
sexual partners and inconsistent 
condom use, and having 5 or more 
sexual partners in the last year among 
HIV+  veterans. 
Desai, R. A., 
Rosenheck, R. A., 
& Agnello, V. 
2003 
Prevalence of Hepatitis C 
Virus Infection in a 
Sample of Homeless 
Veterans 
n=418 treatment-seeking 
homeless veterans  
Abbott HCV EIA 2.0 test 
for HCV antibodies; 
PCR assay test for HCV 
infection in sera; Self-
report data forms 
collected on admission  
Compared profile to that of 
patients enrolled in other 
DCHV programs throughout 




 44.02%  HCV positive prevalence rate 
with significant association to age (40-
50) and to service era (51.35 Vietnam 
era, 42.21 post-Vietnam era).  
 Homeless population was 10 times 
more likely to have HCV positivity 
than the US population of same age 
group. 
 Those veterans who served during the 
Vietnam era were 4.66 times more 
likely to be HCV positive. 
 Those veterans with a lifetime history 
of drug abuse were 6.86 times more 





AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
El-Serag, H. B., 
Kunik, M.,  
Richardson, P., & 
Rabeneck, L.  
2002 
Psychiatric Disorders 
Among Veterans with 
Hepatitis C Infection 




compared with n=43, 267 
non-HCV-infected 
Vietnam veterans 
Data collection from 
chart including ICD-9 
codes and demographics 
Retrospective chart review.  
 
Analyses: univariate 
analyses, chi square, t tests, 
regression analyses  
 85% of HCV+ veterans  had at least 
one past or present psychiatric, drug-
use, or alcohol-use disorder 
diagnosis.1/3 of HCV+ veterans had 
active psychiatric or drug-use 
disorders. Only 6.5% had a psychiatric 
disorder without a drug or an alcohol 
use disorder.  
 42.8 % prevalence of PTSD among 
HCV+ veterans. 
 Among Vietnam-era veterans, there 
was a 4 fold increase in alcohol use, 5 
fold increase in drug use, and  2 fold 
increase in suicide attempts when 
comparing HCV+ and HCV-  veterans. 
Ganguly, R., 
Lenox, B., Quiroz, 
E., & Sinnott, J.  
2002 
HIV Infection, Risk 






generated for the study 
Cross-sectional survey study. 
Self-report measures 
administered onsite with a 




and chi square analysis, 
correlational analyses, 
regression analyses 
 53.3% of veterans sampled had high-
risk factors. More younger veterans 
(age<50) had risk factors than older 
veterans.  
 Most of veterans believed that condom 
use prevented HIV transmission, but 
65.8% of veterans did not use 
condoms. 
  Resistance to condom use was related 
to age, with those <50 years old more 
willing to use condoms.  
 None of the veterans reporting multiple 
sexual partners in the last six months 
used a condom consistently.  
Ho, S. B.,  
Nguyen, H., 
Tetrick, L. L., 
Opitz, G. A., 
Basara, M. L, &  
Dieperink, E.  
2001 
Influence of Psychiatric 
Diagnoses on Interferon-  
Treatment for Chronic 
Hepatitis C in a Veteran 
Population 
n=35 veterans with 
chronic HCV who were 
eligible for IFN treatment  
Complete medical and 
psychiatric history at 
beginning of protocol; 
HCV RNA testing 
throughout treatment 
protocol 
Retrospective review of 
medical records for 
psychiatric diagnoses. 
Participants were enrolled in 
a high dose IFN- treatment 
protocol. All those on anti-
depressant or anti-psychotic 
medications during therapy 
were followed by psychiatric 
service during treatment.  
 
Analyses: contingency table 
and chi square analysis 
 HCV+ veterans with an established 
diagnoses of psychiatric conditions 
prior to treatment experienced a >2 
fold frequency of major adverse events 
resulting in discontinuation of therapy 
or interventions when compared with 
patients without these diagnoses.  
 Four of the five HCV+ veterans 
diagnosed with PTSD experienced a 
major adverse event; however, the n is 






AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Hoff, R. A., 
Beam-Goulet, J., 
& Rosenheck, R. 
A. 1997 
Mental Disorder as a 
Risk Factor for Human 
Immunodeficiency Virus 
Infection in a Sample of 
Veterans 
n=11,645 veterans from 
the National Survey of 
Veterans  
Study-generated 
telephone interview  
Random digit dialing of US 
and Puerto Rican numbers to 
a  random sample of veterans 
from the VA Compensation 
and Pension Files,  VA 
patient treatment files, and 




 37% of sample were HIV+  
 1.44% of those with a diagnosis of 
drug or alcohol abuse were HIV+.   
 1.03% of those with PTSD were HIV+  
 26% of those with PTSD had co-
morbid drug or alcohol abuse.  
 40.52% of those with PTSD had a co-
morbid mental disorder other than 
substance abuse.  
 Those with substance use were 4.9 
times more likely to be HIV+ and those 
with PTSD were 3.17 times more 
likely to be HIV+.  
 Those with PTSD alone were not at 
increased risk but those with substance 
abuse were 2.43 times more likely to 
be HIV+ and those with both were 
11.50 times more likely to be HIV+.  
Huckans, M. S., 
Blackwell, A. D., 
Harms, T. A., & 
Hauser, P.  2006 
Management of Hepatitis 
C Disease Among VA 
Patients With 
Schizophrenia and 
Substance Use Disorders 
n=293,445 treatment-
seeking veterans  
Used database to collect 
demographic data, 
psychiatric diagnoses, 
HCV laboratory results, 
and prescriptions. 




statistics, odds ratios 
 11.4% veterans tested HCV+ 
  High risk groups were significantly 
more likely to test HCV antibody 
positive.  
 Veterans in high-risk groups were less 
likely to receive IFN therapy if they 
were in the substance disorders or co-
occurring disorders groups.  
Hyams, K. C., 
Riddle, J., 
Rubertone, M., 
Trump, D., Alter, 
M. J., Cruess, D. 
F., et al. 2001. 
Prevalence and Incidence 
of Hepatitis C Virus 
Infection in the US 
Military: A 
Seroepidemiologic 
Survey of 21,000 troops. 
n=21,000 military 
personnel (n=10, 000 
active duty, n=2,000 
active duty inducted in 
2007, n=2000 reservists, 
n=1000 active duty who 
served in Vietnam, n= 
2000 active duty who 
retired in 1997 after 20+ 
years of service, n=2000 
women on active duty, 
n=1000 non-white/non-
African American active 
duty, n=1000 active duty 




and  recombinant 
immunobloat assay 
(RIBA) to determine 
HCV-positivity; HCV 
RNA testing 
Proportion of each group was 
chosen in proportion to 
number of individuals from 
each branch of the military. 
Serum samples from the 
Department of Defense 
Serum Repository were used 
for HCV analyses.  
 
Analyses: chi square, t-tests, 
regression analyses 
 HCV prevalence rates were 
substantially lower than those of the 
civilian population less than 40 years 
of age (0.1% among those >35 years; 
1.1% among those 35-39 years).  
 Prevalence rates of older personnel 
were comparable to the civilian 
population (3.0% among those 40+ 
years).  
 Potentially high risk groups such as 
health care personnel and Vietnam era 
veterans did not have an increased risk 





AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Johnson, J. E., 
Finney, J. W., & 
Moss, R. H. 2005 
Predictors of 5-year 
Mortality Following 
Inpatient/Residential 
Group Treatment for 
Substance Use Disorders 
n=3,698 male SUD 
treatment inpatient 
veterans 







at intake, discharge, and 12-
months post-discharge. Used 
VA Beneficiary 
Identification and Record 
Locator System database to 
verify and ascertain death 
status for those who could 




 HIV/AIDS status was the strongest 
predictor of mortality in the sample.  
 Those who were HIV-, who consumed 
less than 3oz of ethanol on non-
drinking days, who were employed, 
and who were partnered 1 year after 
discharge had a dramatically decreased 
risk of death within the next 5 years 
(5%) than those who were not (56%). 
Justice, A. C., 
McGinnis, K. A., 
Atkinson, J. H., 
Heaton, R. K., 
Young, C.,  Sadek, 
J., et al. 2004 
Psychiatric 
Neurocognitive Disorders 
Among HIV-positive and 
Negative Veterans in 
Care: Veterans Aging 
Cohort Five-Site Study 
n=50 veterans 
(convenience sample) who 
were part of the Veterans 
Aging Cohort 5-site Study 
who consented to 
participate in formal NCP 




WRAT-3; WAIS III 
(Digit Symbol, Symbol 
Search, Letter-Number 
Sequencing); Trail 
Making Test Part A & B; 
Paced Auditory Serial 
Addition Task; 
Controlled Oral Word 
Association; Hopkins 
Verbal Learning Test - 
Revised (Total Trials 1-3 
& Delayed Recall); Brief 
Visuospatial Memory 
Test- Revised (Total 
Trials 1-3 & Delayed 
Recall); Wisconsin Card 
Sorting Test; Grooved 





Alcohol and drug use 
confounds were determined 
by interviewer based on 
interview, ICD-9 diagnoses, 
and self-report screening 
measures. Blind clinical 
rating to characterize the 
presence of global NCP 
impairments. 
 
Analyses: kappa statistics, 
chi square tests, regression 
analyses 
 Older HIV+ veterans demonstrate 
higher rates of depressive symptoms, 
alcohol abuse or dependence, and drug 
abuse or dependence than age-stratified 





AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Lehman, C. L., & 






Veterans With Chronic 
Hepatitis C 
n=120 veterans with HCV 








Veterans underwent a 
physical exam, psychiatric 
interview, and self-report 
medical history was 
collected. Retrospective 
medical chart review for 
preexisting psychiatric 
diagnosis. The Post-
Traumatic Stress Disorder 
Check List was only 
administered to those who 
reported history of 
significant trauma. The 
AUDIT was only 
administered to those who 
admitted alcohol use in the 
last 12 months.  
 
Analyses: independent t 
tests, Pearson R correlations 
 49.4% of HCV+ veterans had a history 
of non-substance abuse psychiatric 
disorders and 81% had a history of an 
alcohol use disorder.  
 Clinically significant levels of PTSD 
(20.8%) and alcohol-related problems 
(26.7%) were observed.  
 Positive correlations were found 
between PTSD symptoms and alcohol 
use problems.  
 Coexisting unstable psychiatric 
disorders and/or recent substance use 
was found in 73.4% of the veterans.  
Lim, J. K., 
Cronkite, R., 
Goldstein, M. K., 
& Cheung, R. C. 
2006 
The Impact of Chronic 
Hepatitis C and 
Comorbid Psychiatric 
Illness on Health-related 
Quality of Life 
n=864 veterans who 
participated in the 1999 
Large Health Survey and 
had been tested for anti-
HCV  




diagnoses were determined 
from VHA administrative 
databases.  
 
Analyses: chi square tests, t 
tests, regression analyses 
 Anti-HCV+ veterans were more likely 
to be younger, male, nonwhite, and 
unmarried.  
 Anti-HCV+ veterans were more likely 
to have at least 1 of 6 psychiatric 
diagnoses, including PTSD (27.9%), or 
alcohol dependence (43.8%).  
 Health related quality of life was 
significantly lower for anti-HCV+ 
veterans on role emotional, mental 
health, general health, and social 
functioning. Those with PTSD 





AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Nguyen, H. A., 
Miller, A. I., 
Dieperink, E., 
Willenbring, M. 
L., Tetrick, L. L., 
et al. 2002 
Spectrum of Disease in 
U.S. Veteran Patients 
with Hepatitis C 
n=206 veterans with HCV 
who met eligibility criteria 
for interferon a -2b 
therapy  
Qualitative  polymerase 
chain reaction assays 
(PCR) for HCV; Liver 
biopsies;  
Review of medical records 
for ICD-9 codes and 
treatment for alcohol use 
history and psychiatric 
diagnoses. Treatment 
included Interferon a-2b 
monotherapy or a 
combination therapy of 
interferon and ribavirin. PCR 
performed before treatment 
initiation, at 3-6 months, at 
the end of 6-12 months, and 




tables, chi square analyses 
 Psychiatric illnesses were present in 
60% of patients, with the most 
common diagnosis being depression or 
PTSD.  
 A history of alcohol use or dependence 
was found in 80%  and a  history of 
IVDU or cocaine use in 78% of 
veterans sampled.  
 A majority of HCV+ veterans sampled 
(77%) served during the Vietnam era 
and 66% had a history of IVDU. 
 Significant liver fibrosis is common in 
the patients with psychiatric diagnoses 
when they are initially evaluated for 
treatment. . The rates of liver fibrosis 
seen are higher than those in the 
general population. 
 
Roselle, G. A., 
Danko, L. H.,  
Kralovic, S. M., 
Simbarti, L. A., & 
Kizer, K. W. 2002 
National Hepatitis C 
Surveillance Day in the 
Veterans Health 
Administration of the 
Department of Veterans 
Affairs 
n=26,102 treatment 
seeking veterans from 138 
of 142 reporting sites 
Diversity of serologic 
methods for HCV-
antibodies 
VHA patients having lab 
studies performed were 
asked to undergo HCVAb 
testing at 142 VHA sites. 
Data were collected at each 
site and extracted from VHA 
electronic surveillance 
systems and sent to the 
Austin Automation Center.  
 
Analyses: t-tests, odds ratios, 
regression analyses 
 HCVAb prevalence rates of 6.6% were 
found.  
 Those who were HCVAb seropositive 
were likely to be Vietnam era veterans. 
Roselle, G. A., 
Mendenhall, C. L., 
& Danko, L. H. 
1997 
A Four-Year Review of 
Patients with Hepatitis C 
Antibody in Department 
of Veterans Affairs 
Facilities 
n=168 Department of 
Veterans Affairs sites 
Census instrument asking 
for the number of 
patients who tested 
positive in the designated 
fiscal year (from 1991-
1994), also included 
common causes of 
infectious hepatitis as 
well as emerging 
pathogens 
Data reviewed and analyzed 





 Increase of 285% in positive tests for 
HCV antibody from 1991-1994 among 
client population that only increased 





AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Seal, K. H., 
Currie, S. L., 
Shen, H.,  Anand, 
B. S.,  Bini, E. J.,  
Brau, N., et al. 
2007 
Hepatitis C Treatment 
Candidacy and Outcomes 
Among 4318 US 
Veterans with Chronic 
Hepatitis C Virus 
Infection 
n=4,462 treatment-
seeking veterans from 24  




drug and sexual risk 
behavior 
Clinical assessments 
including detailed medical 
and mental health history and 
laboratory tests were done to 
determine treatment 
candidacy using VA HCV 
Treatment 
Recommendations. 
Treatment with Rebetron for 
up to 24-28 weeks. Veterans 
returned for follow-up at 
week 1, 2 and months 1, 3, 6, 
9, and 12 to monitor 
treatment compliance, 
physical and psychiatric side 




 61% of those evaluated for HCV 
treatment reported a history of IVDU 
and were significantly more likely to 
be Vietnam-era veterans who drink 
more than 3 alcoholic drinks a day in 
the last year, engage in high risk sexual 
behavior, and are HIV seropositive.  
 IVDU  was not significantly associated 
with HCV treatment candidacy, 
treatment acceptance, early 
discontinuation of therapy, or treatment 
response.  
Srauss, J. L., 
Bosworth, H. B., 
Stechuchak, K. 
M.,  Meador, K. 
M., & Butterfield, 
M. I. 2006 




Veterans with Severe 
Mental Illness 
n=353 psychiatric 
inpatient veterans (45% 
Schizophrenia, 16% 
Bipolar I, 39% PTSD) 
Standardized semi-
structured assessment 
interview; select items 
from AIDS Risk 
Inventory; Dartmouth 
Assessment of Lifestyle 
Instrument 
Interview conducted by 
experienced interviewers and 
adapted from an established 
instrument. Review of 
medical records and 
psychiatric records and 
current admission records for 




 More than 40% of participants 
answered at least one AIDS related 
knowledge question incorrectly. 
 Most common incorrect answers were: 
"Most people become sick quickly 
after getting the AIDS virus" (31.4%) 
and "People who can give you the 
AIDS virus always look sick" (15.9%).   
 Inaccurate HIV knowledge was not 
associated with clinical diagnosis.  
Szerlip, M. A., 
Desalvo, K. B., & 
Szerlip, H. M. 
2005 
Predictors of HIV-
Infection in Older Adults 
n=53 HIV+ veterans and 




Retrospective chart review 
for potential HIV predictors 
HIV risk behaviors, history 
of diseases associated with 
HIV risk or infection and 
routine laboratory values, 
non-HIV related comorbid 
diseases requiring chronic 





 HIV+ veterans exhibited significantly 
more alcohol abuse than HIV- 
veterans.   
 HIV+ veterans were more likely to 
have a history of sexually transmitted 
diseases such as syphilis, gonorrhea, 
Chlamydia or herpes and were more 
likely to  test VDRL positive, have 
previous HBV exposure, and have a 





AUTHORS TITLE PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Yovtcheva, S. P., 
Rifai, M. A., 
Moles, J. K., & 
Van der Linden, 




n=306 HCV+ veterans  
Retrospective chart 
review 
Retrospective chart review 
for demographics and 
psychiatric disorders. 
Symptoms in medical 
records compared with 





 Prevalence rates of a variety of 
psychiatric disorders were higher in 
HCV+ veterans than the general 
population.  
 Alcohol use disorders were the most 
common (86%) followed by 
polysubstance use (60%) and IVDU 







Substance Use Disorders Literature Table   n=20 
AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Boudewyns, P .A., 
Albrecht, J. W., 
Talbert, F. S., & 
Hyer, L. A. 1991 
Comorbidity and 
Treatment Outcome of 
Inpatients with Chronic 
Combat-related PTSD 
n=102 inpatient male 
Vietnam combat veterans 





data collected from record 
review.  
 
Analyses: chi square analyses  
 All participants exhibited the presence 
or history of one co-morbid Axis I 
disorder. 
 91% exhibited lifetime history of 
alcohol, drug, or mixed alcohol and 
drug abuse or dependence.  
Boudewyns, P. A., 
Woods, M. G., 
Hyer, L., & 
Albrecht, J. W. 
1991 
Chronic Combat-related 
PTSD and Concurrent 
Substance Abuse: 
Implications for 
Treatment of this 
Frequent 'Dual 
Diagnosis' 
n=102 inpatient male 
Vietnam combat veterans 




PTSD was determined by a 
Diagnostic Interview 
Schedule and independent 
diagnosis by the unit staff.  
 
Analyses: chi square analyses  
 91.2% of veterans had at least a 
lifetime diagnosis of some form of 
substance abuse/dependence. 
 32% admitted to drug/alcohol use in 
the last 6 months.  
 A strong connection between 
substance abuse/use and stress was 
noted. 
 Those veterans with a diagnosis of 
alcohol abuse/dependence in last year 
were less likely to complete the PTSD 
treatment program.  
Bremner, J. D., 
Southwick, S. M., 
Darnell, A., & 
Charney, D. S. 
1996  
Chronic PTSD in 
Vietnam Combat 
Veterans: Course of 
Illness and Substance 
Abuse 
n=61 treatment-seeking 
combat veterans with 
combat-related PTSD 





Longitudinal History for 
Vietnam Veterans 
Interview; Structured 
Clinical Interview for 
PTSD from DSM-III-R; 
Addiction Severity Index 
Interview; Author-
generated assessment for 
stressful life events 
Record review for history of 




correlations, t tests 
 PTSD symptoms were noted to 
plateau, become chronic, and 
gradually increase within a few years 
of the war.  
 The course of alcohol and substance 
abuse followed a pattern similar to 
that of PTSD in the period during and 
immediately following the war.  
 Veterans reported that alcohol, heroin, 
marijuana, opiates, and 
benzodiazepines were beneficial in 
mitigating their symptoms of PTSD.  
Davidson, J, 
Kudler, H., 
Saunders, W., & 
Smith, R. 1990 
Symptom and 
Comorbidity Patterns in 
World War II and 




male veterans with PTSD 
(19 WWII, 25 Vietnam) 
Hamilton Depression and 
Anxiety Scale; Newcastle 
Index; Clinical Global 
Impression of Severity of 
Illness; Impact of Events 
Scale; Symptom 
Checklist-90; SI-PTSD; 
Schedule for Affective 
Disorders and 
Schizophrenia 
Patients were assessed at 
baseline by a physician. 
Baseline ratings were taken 
after the patients had been 
free of medication for at least 
10 days.  
 
Analyses: chi-square tests 
 Vietnam veterans appeared more 
symptomatic and more severely 
affected with respect to observed 
depression and PTSD 
symptomatology.  
 Assessment showed a high frequency 
of alcoholism (47% WWII, 68% VN).  
 Alcoholism preceded or occurred at 
the same time as PTSD in Vietnam 
veterans but followed PTSD 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Eisen, S. A., 
Griffith, K. H., 
Xian, H., Scherrer, 
J. F., Fischer, I. D., 
Chantarujikapong, 
S. et al. 2004 
Lifetime and 12-month 
Prevalence of 
Psychiatric Disorders in 
8169 Male Vietnam War 
Era Veterans 
n=8,169 male Vietnam 
era veterans 
National Institute of 
Mental Health Diagnostic 
Interview Schedule 
Instrument administered by 
telephone using a 
computerized version of the 
DIS-III-R.  
 
Analyses: odds ratios, 
descriptive statistics 
 55% exhibited a lifetime prevalence 
and 17% had a 12-month history of 
alcohol abuse and /or depression.  
 10.2% exhibited a lifetime history and 
1.3% had a 12-month history of illicit 
drug abuse and/or dependence. 
Faustman, W. O., 









n=536 male veterans 
with  PTSD or 
provisional diagnosis of 
PTSD (n=139 from 
Psychiatric Ward [PW] 
and n=397 Stress 
Disorder Program [SDP]) 
Discharge Summaries  
Retrospective chart review; 
8000 records from inpatient 
psychiatric services were 
reviewed and 536 veterans 
with PTSD or provisional 
PTSD were identified. The 
536 PTSD veterans were 
rated based on demographics, 
discharge diagnosis, alcohol 
and/or substance abuse, and 
psychotropic medications.  
 
Analyses: Descriptive 
statistics; separate data 
analyses were performed for 
the PW and SDP groups.  
 Alcohol abuse (23.3%) and alcohol 
dependence (13.1%) were the most 
frequent concomitant diagnoses found 
with PTSD. 
 18% of the veterans were found to 
have an alcohol abuse history that was 
not represented by an Axis I diagnosis 
in their charts.  
 56% of the SDP and 36% of the PW 
chart summaries noted current and/or 
remote history of maladaptive alcohol 
use or drug use.  
Green, B. L., 
Grace, M. C.,  
Lindy, J. D.,  
Gleser, G. C., & 
Leonard, A. L. 
1990  
Risk factors for PTSD 
and Other Diagnoses in a 
General Sample of 
Vietnam Veterans 
n=200 male veterans (1/3 
from clinical sources and 
2/3 non-treatment 
seeking) 
Schedule of Affective 
Disorders and 
Schizophrenia Lifetime 
Version; 6-point scale of 
Psychosocial Adjustment 
in Adolescence; SADS:L; 
Wilson and Krauss 







Scale   
3 1/2 hour interviews  
 
Analyses: regression analyses 
 Premilitary factors contributed 9% to 
the prediction of PTSD; however 
military factors played a larger role, 
accounting for 19% of the variance 
over and above premilitary factors.  
 Post-military factors accounted for an 
additional 12% of the variance over 
and above both premilitary and 
military factors and explained 
significant variance in the diagnosis of 
alcohol and drug abuse.  
 The strongest predictor of PTSD was 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Hryvniak, M. R. 
1989 
Concurrent Psychiatric 
Illness in Inpatients with 
Post-traumatic Stress 
Disorder 
n=374 inpatient veterans 
in general psychiatry 
ward 
Diagnostic Interview 
Diagnoses made using DSM-
III and DSM-III-R criteria, by 
ongoing observation, and 
appropriate review of hospital 
records, collaboration from 
family members, consultation 
with previous treating 
physicians, and assessment 
with psychological testing.  
 
Analyses: chi-square 
 Mean number of diagnoses for the 
PTSD group was 2.9, compared with 
1.4 in non-PTSD group.  
 Concurrent diagnoses most often 
associated with PTSD were alcohol 
abuse (42.9%), substance use and 
depression (36.5%).  
 Alcohol abuse occurred significantly 
more frequently among the PTSD 
group. 
Johnson, D. R., 
Fontana, A., Lubin, 
H., Corn, B., & 
Rosenheck, R. 2004 
Long-term Course of 
Treatment Seeking 
Vietnam Veterans with 
Posttraumatic Stress 
Disorder: Mortality, 
Clinical Condition, and 
Life Satisfaction 
n=51 inpatient treatment-
seeking male veterans 
with PTSD 
Mississippi PTSD Scale; 
War Stress Interview 
Follow-up Version; 
Clinician Administered 
PTSD Scale; Combat 
Exposure Scale;  
6-year longitudinal study with 
assessment at admission, 18 
months, and 6 years.  Combat 
experience was confirmed by 
review of military files. 
Veterans were questioned 
about experience with and 
frequency of 11 categories of 
stressful life events at 6 year 
follow-up, were asked to rate 
10 dimensions of functioning 
at 3 time periods, and were 
asked to rate the  degree of 
impact of treatment program 
on same 10 dimensions.  
 
Analyses: ANOVA, 
regression analyses, t-tests 
 There was a 17% mortality rate over 6 
years. This rate is 5 times higher than 
the expected rate among American 
men in this age range.   
 More convictions, more medical 
problems, greater need for help with 
drug abuse, and fewer employers 
since military discharge were 
significantly associated with veteran 
death.   
 Most of causes of death appear to be 
associated with either self-destructive 
or high-risk behavior. 
Kulka, R. A., 
Schlenger, W. E., 
& Fairbank, J. A. 
1990 
Trauma and the Vietnam 
War Generation: Report 




n=1200 male Vietnam 
theatre veterans, n=412 
male Vietnam era 
veterans, n=450 male 
civilian comparison 
subjects from the 
NVVRS 
Mississippi Combat-
Related PTSD Scale; 
MMPI; Structured 
Clinical Interview for the 
DSM-III 
Connected to veterans via 
telephone.  
 
Analyses: unable to 
determine. 
 Male Vietnam theatre veterans had 
high levels of lifetime alcohol 
dependence or abuse (40%) when 
compared with civilian males (25%).  
 6% lifetime drug abuse rates for male 
Vietnam theatre veterans.  
 Almost three-fourths of veterans with 
PTSD had a lifetime alcohol abuse or 
dependence disorder, and 22% had 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
McFall, M. E., 
Mackay, P. A., & 
Donovan, D. M. 
1992 
Combat-related PTSD 
and Severity of 
Substance Abuse in 








Mississippi Scale for 
Combat-Related PTSD; 
Michigan Alcohol 
Screening Test; DAST 
3-hour orientation at intake to 
Addictions Treatment Center 
during which time the battery 
of assessments was 
administered. Demographic 
data, including military 
history variables, were 
obtained from the self-report 
version of the Addiction 
Severity Index.  
 
Analyses: t-tests, chi-square, 
correlations, regression 
analyses 
 92% of total veterans presented with 
alcohol-abuse disorder, 60% with a 
drug-abuse disorder, and 53% with 
both alcohol and drug abuse disorders.  
 Combat-exposed veterans with PTSD 
have more severe alcohol and drug-
abuse problems than theatre veterans 
without PTSD.  
 PTSD veterans were at greater risk for 
concurrent dependence on both 
alcohol and drugs than non -PTSD 
theatre veterans.  
 Overall severity of PTSD was more 
strongly associated with drug abuse 
than alcohol abuse.  
 Physiological arousal and ideational 
reexperiencing were significantly 
correlated with MAST scores while 
the DAST was positively related to 
avoidance/numbing.  
McFall, M. E., 
Mackay, P. W., &  








male veterans with 
substance abuse disorders  
Modified Addiction 
Severity Index; Revised 
Combat Scale; 
Mississippi Scale for 
Combat-related PTSD 
3 hour orientation session 
with a clinical interview and 
administration of the 
psychometric instruments.  
 
Analyses: t-tests, regression 
analyses, chi-square 
 46% of Vietnam theatre veterans 
presented  with clinically significant 
PTSD symptoms. 
 PTSD contributed to the prediction of 
history of psychiatric hospitalizations, 
lifetime trouble with thoughts of 





Raskind, M., & 
Rosenheck, R. 1999 
Analysis of Violent 






male Vietnam combat 
veterans , n=64 male 
veteran psychiatric 
inpatients with no history 
of combat exposure or 
PTSD, n= 273 male 
Vietnam veterans with 
PTSD who had never 
been hospitalized on a 
VA inpatient psychiatry 
unit from NVVRS data 
set 
Revised Combat 
Exposure Scale (to 
n=58); Mississippi Scale 
for Combat-Related 
PTSD (brief version); 
National Comorbidity 
Survey (comparison 
group); PTSD Screening 
Form; War Stress 
Interview - Admissions 
Supplement; 10-item 
RCES; War Stress Intake 
Questionnaire; PTSD 
Discharge Process Form 
Standard clinical interview to 
determine PTSD diagnosis 
(DSM-III-R); Self-report of 
violent acts for inpatient 
groups similar to items on the 
NVVRS, also derived by 
direct interview and review of 
medical records; Violent acts 
by community residents 
assessed by adaptation of the 
Conflict Tactics Scale 
 
Analyses: odds ratios, chi-
square tests, regression 
analyses 
 Among the inpatient PTSD group, 
54% had alcohol abuse-dependence 
and 32% had drug abuse-dependence  
 PTSD inpatients were significantly 
more likely than psychiatric inpatients 
without PTSD to have engaged in one 
or more violent acts during the 4 
months prior to hospitalization and 
were significantly more violent than 
the NVVRS sample.  
 PTSD, atrocities, and substance use 
contribute to the variation in violence.  
 A significant proportion of PTSD 
inpatients were classified as highly 
violent when compared with the non-
PTSD inpatients and community 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Norman, S. B., 
Tate, S. R., 
Anderson, K. G., & 
Brown, S. A. 2007 





male veterans (n= 68 
SUD-only, n=34 SUD-
Trauma, and n=32 SUD-
PTSD) 
Semi-Structured 
Assessment for the 
Genetics of Alcoholism, 
Lifetime Version; Brief 
Symptom Inventory; 
Timeline FollowBack for 
Substance Use; Tox 
screen (20% of 
participants); Contextual 
Cue Assessment  
Diagnostic interviews 
conducted to assess lifetime 
and current PTSD; Charts 
screened for potential 
participants; Structured 
interviews 2 weeks after 
abstinence; Telephone 
contacts at 4 post-treatment 
time periods and in-person 
interviews at 4 post-treatment 
time periods; Interview of 
collateral contact person 
quarterly 
 
Analyses: regression analyses 
 SUD-PTSD and SUD-Trauma groups 
did not have worse post-treatment 
outcomes than SUD-only group 
 Those with trauma histories reported 
significantly higher psychiatric 
symptom scores than the SUD-only 
group prior to relapse.  
 SUD-PTSD patients had significantly 
more anxiety and total symptoms than 
SUD-Trauma.  
 Higher levels of anxiety and PTSD 
symptoms predicted an increased 
likelihood of relapse in negative 
interpersonal contexts and negative 
physiological contexts, but a reduced 
likelihood of drinking in the context 
of social pressure 
Price, R. K., Risk, 
N. K., Haden, A. 
H., Lewis, C. E., & 





Suicidality among Male 
Vietnam Veterans with a 
History of Heavy Drug 
Use 
n=641 Vietnam veterans 
who were in the original 
VES cohort  
VES Survey 
Death certificates were used 
to identify those who 
committed suicide with 
external causes of death 
qualifying for suicide coded 
by an expert cause-of-death 
coder. Non-fatal suicidality 
was determined by answers to 
questions about frequent 
thoughts of suicide, making a 




statistics, t-tests, ANOVAs 
 Remission from suicidality occurred 
more slowly for veterans with 
concurrent PTSD or with concurrent 
drug dependence.  
 Drug dependence had the second 
largest effect, following depression, 
on suicidal timing.  
Roszell, D. K., 
McFall, M. E., & 
Malas, K. L. 1991 
Frequency of Symptoms 
and Concurrent 
Psychiatric Disorder in 
Vietnam Veterans with 
Chronic PTSD 
n=116 male Vietnam 
veterans referred for 
PTSD evaluation 
SCID-P 
n=48 had 4-6 hours of 
clinical interviewing to assess 
for military history and DSM-
IIIR Axis I mental disorders 
using SCID-P; n=68 only 
administered the PTSD 
portion of the SCID-P 
 
Analyses: correlations 
 36.8%  of veterans reported alcohol or 
nonprescription substance use to avoid 
dealing with memories or feelings 
associated with the trauma.  
 Alcohol abuse diagnosed in 4.2%, 
alcohol dependence 33.3%, drug 
abuse 4.2%, drug dependence 10.4%. 
 Symptoms of reexperiencing were 
significantly related to symptoms of 
avoidance or numbing and 
physiological arousal.  
 Avoidance or numbing symptoms 
were significantly correlated with 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Steindl, S. R., 
Yound, R. M., 
Creamer, M.  
Crompton, D. 2003 
Hazardous Alcohol Use 
and Treatment Outcome 














CAPS used to confirm 
diagnosis. AUDIT, PCL and 
demographic information 
collected at intake. Measures 
were given at intake and 9-
month follow-up.  
 
Analyses: MANOVA, t-tests, 
ANOVA, regression analyses 
 68% of veterans were classified as 
hazardous drinkers at intake. 
 Drinking status was significantly 
associated with PTSD symptoms at 
follow-up.  
 Unchanged hazardous drinkers 
experienced more severe avoidance, 
numbing, and arousal symptom when 
compared to new low-risk drinkers at 
9-month follow-up.  
 Unchanged hazardous drinkers had 
more severe arousal symptoms when 
compared to unchanged low-risk 
drinkers.  
Sutker, P. B., Uddo, 
M., Brailey, K.,  
Vasterling, J. J., & 
Errera, P. 1994 
Psychopathology in 
War-zone Deployed and 
Nondeployed Operation 
Desert Storm Troops 
Assigned Graves 
Registration Duties 
n=60 US Army 
Reservists (n=40 
deployed to the Persian 
Gulf and n=20 stateside) 
Demographic 
Questionnaire; Shipley 
Institute of Living Scale; 
Graves Registration Duty 
Scale; SCID-P for Axis I 
Disorders; State-Trait 
Anxiety Inventory; State-




Assessment and debriefing 
conducted approximately 12-
months after termination of 
duties. Self-report instruments 
were administered as well as 
individually-administered 
structured clinical interviews, 
and small-group debriefing 
sessions. War-zone stress 
exposure was characterized 
by a count of total days of 
war-zone exposure as well as 




 A significantly greater number of 
deployed troops had a diagnosis of 
PTSD than those who were remained 
stateside (48% vs. 0% current PTSD; 
65% vs. 0% lifetime PTSD).  
 PTSD diagnoses were frequently 
associated with alcohol dependence 
(21% current diagnosis; 31% lifetime 
diagnosis) and substance dependence 
(5% current diagnosis; 4% lifetime 
diagnosis) 
Tate, S. R., 
Norman, S. B., 
McQuaid, J. R., & 
Brown, S.A. 2007 
Health Problems of 
Substance-Dependant 
Veterans with and 
without Trauma History 
n=121 treatment-seeking 
male veterans (n=55 
SUD-only, n=34 SUD-
Trauma, and n=32 SUD-
PTSD groups) 
Brief Symptom Inventory 
(at intake and each 
follow-up); Modified 
Psychiatric Epidemiology 
Research Interview and 
structured interview for 
more detail; Semi-
Structured Assessment 




Substance Use; Tox 
screen for 15% of 
participants 
Assessments and interviews 
completed after admission 
and 2 weeks of abstinence, 
and quarterly for a year 
thereafter. Self-ratings of 
current health status, tobacco 
use, and number of medical 
treatment contacts made for 
physical health in prior three 
months. Self-report of 
number of professionally led 
addiction, dual-diagnosis, 
mental health and 12-step 




ANOVA, regression analyses 
 Veterans with SUD and PTSD 
exhibited the highest rates of chronic 
health problems; however, no 
significant difference was found 
between the SUD-Trauma group and 
SUD-PTSD group.  
 SUD-PTSD and SUD-Trauma 
patients rated their health as worse 
and had a greater utilization of 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Vaidya, N. A., & 
Garfield, D. A. S. 
2003 









male veterans with 
substance abuse diagnosis 
only and n=30 treatment-
seeking male PTSD 
veterans 
TCI 
Retrospective chart review. 
PTSD patients were given the 
TCI as a part of their clinical 
assessment. PTSD was 
determined by a researcher 
using DSM-IV criteria.  
 
Analyses: t-tests 
 Scores differed between PTSD 
veterans and SUD veterans on the 
TCI.  
 PTSD veterans reported average 
novelty seeking, high harm avoidance, 
and low reward dependence while 
substance abuse patients had high 
novelty seeking, average harm 
avoidance, and average reward 
dependence.  
 Authors suggest that the findings may 
support the hypothesis that PTSD 
patients use substances to mitigate 






Sleep Disturbances Literature Table  n=15 
AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Aukst-Margetic, B., 
Margetic, B., Tosic, 
G., & Bilic-Prcic, 
A. 2004 
Levomepromazine 
Helps to Reduce Sleep 
Problems in Patients 
with PTSD 
n=21 in- and outpatient 
veterans with severe 





Participants had not used 
alcohol or other substances 
for 6 months. Participants 
were medicated for trauma 




added. Results were evaluated 
in week 4.  
 
Analyses: t-test 
 Veterans experienced a significant 
decrease in CAPS recurrent 
distressing dream items, as well as 
prolonged sleep and less subjective 
sleepiness after waking.  
 Examined sleep latency, total hours of 
sleep, and recurrent distressing 
dreams.  
David, D., De Faria, 
L., & Mellman, T. 
2006 
Adjunctive Risperidone 
Treatment and Sleep 
Symptoms in Combat 
Veterans with Chronic 
PTSD 






Scale; Pittsburgh Sleep 
Quality Index; Sleep 
Diaries 
Open-label, flexible-dose 
trial. Risperidone was started 
with 1mg and titrated up until 
subjects reported 
improvement in target 
symptoms and/or developed 





 Total CAPS score and specific items 
identifying recurrent distressing 
dreams and difficulty falling or 
staying asleep were improved at 6 
weeks.  
 Sleep logs showed nighttime 
awakenings had decreased and there 
was a reduction in the proportion of 
diaries documenting trauma dreams at 
6 weeks.  
 Examined nightmares, sleep 
disruption, PTSD.  
Engdahl, B., Eberly, 
R., Hurwitz, T., 
Mahowald, M., & 
Blake, J. 2000 
Sleep in a Community 
Sample of Elderly War 
Veterans with and 
without Posttraumatic 
Stress Disorder 
n=59 elderly male war 
veterans exposed to war 
trauma (n= 30 with 
PTSD diagnosis) 
Structured Clinical 
Interview for DSM-III-R 
PTSD module; SCID 
Non-Patient Edition; 
Combat Exposure Scale; 
Urine Toxicology Screen, 
Polysomnography 
Sleep lab study. Three 
successive nights of 
polysomnography with urine 
toxicology screen done prior 
to each night. Subjects retired 
at normal bedtime and awoke 
spontaneously. Subjects rated 
their sleep quality and 
quantity after each 
awakening. A multiple sleep 
latency test was performed 
during the day following the 




 Veterans with PTSD had a higher 
percentage of REM sleep and 
exhibited fewer arousals from NREM 
sleep.  
 Veterans with PTSD reported more 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Husain, A., Miller, 
P. & Carwile, S. 
2001 





n=53 veterans (34 
veterans with REM Sleep 
Behavior Disorder (RSB) 
and PTSD, 12 veterans 
with RSB only, and 7 
veterans with PTSD only) 
Polysomnography 
Sleep lab study and 
retrospective chart review. 
Charts reviewed for 
validation of RBD diagnosis. 
PTSD diagnosis based on 
DSM-IV criteria and 
established through 
psychiatric interview. PTSD 
patients screened for drug 
use.  
 
Analyses: students t-test, 
Mann Whitney U test 
 RSB/PTSD and PTSD groups 
reported frightening content of 
dreams. 
 Dreams/Nightmares were related to 
past trauma in all RSB/PTSD and 
PTSD patients but only in 42% of 
RSB patients.  
 Sleep efficiency was significantly less 
in PTSD group when compared to 
PTSD/RSB group.  
 Periodic movements of sleep were 
significantly elevated in PTSD group 
when compared to other groups.  
 REM latency and arousal index were 
not significantly different between 
groups.  
Inman, D. 1990 
Sleep Disturbance in 
Post-Traumatic Stress 
Disorder: A Comparison 
with Non-PTSD  
n=35 Vietnam combat 
veterans in PTSD 
treatment and n=37 
treatment-seeking 
subjects with insomnia 
Structured Clinical 
Interview for DSM-III-R 
PTSD module; MMPI; 
Sleep Disturbance 
Inventory 
PTSD diagnosis determined 
by SCID and MMPI. Subjects 
participated in a 1/2 hour 
structured interview.  
 
Analyses: t-test 
 No difference in the severity of 
insomnia reported by PTSD patients 
and by those with general insomnia 
was found.  
 Insomnia associated with PTSD was 
characterized by greater anxiety, 
higher levels of psychomotor activity, 
and leaving the sleep environment.  
 Fears concerning falling asleep, fear 
of the dark, intrusive thoughts of 
Vietnam, and other anxiety thoughts 
are present among veterans with 
PTSD.  
 Veterans with PTSD recalled more 
dreams than did non-PTSD 
insomniacs and reported more 
repetitive dreams if the content is 
Vietnam-related.  
 PTSD veterans often had difficulty 
returning to sleep after having a 
nightmare. 
Jukic, V. 1999 





n=150 Croatian male 
former prisoners of war 
with PTSD, n=150 
Croatian male combat 
veterans with PTSD, and 
n= Croatian female 
refugees  with PTSD 
Questionnaire created for 
the study (included 
demographics, trauma 
experience, duration of 
psychiatric treatment and 
sick-leave, appearance, 
frequency and intensity 
of sleep disturbances and 
nightmares)  
All PTSD diagnoses were 
reexamined using the DSM-
IV diagnostic criteria. 
Questionnaire filled out by an 
examiner after a detailed 




 High frequency of nightmares and 
other sleep disturbances (87.2%)  in 
war victims with PTSD with no 
statistically significant differences 
between groups.   
 Nightmares were most frequent in 
prisoners of war (82%) while their 
frequency was significantly lower in 
the groups of combat veterans 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Leskin, G. A., 
Woodward, S. H., 
Young, H. E., & 
Sheikh, J. I. 2002 
Effects of Comorbid 
Diagnoses on Sleep 
Disturbances in PTSD 
n=591 men (52%) and 
women (48%) diagnosed 





(n=186), PTSD (n=281) 
National Comorbidity 
Survey 
Retrospective chart review. 
Reviewed data collected in 
the National Comorbidity 
Survey, looking at individuals 
with PTSD and PTSD with 
comorbid disorders. 
Examined the proportion of 
patients complaining of 
nightmares and difficulties 
initiating or maintaining sleep 
for each of these diagnostic 
groups.  
 
Analyses: chi-square analyses 
 High frequencies of nightmares, 
insomnia, and exaggerated startle 
response were reported in all PTSD 
and PTSD/comorbid disorder 
participants.  
 Frequencies ranged from 71-94% 
nightmares, 80-100% insomnia, and 
61-88% exaggerated startle response.  
Mellman, T. 1997 
A Polysomnographic 
Comparison of Veterans 
with Combat-Related 
PTSD, Depressed Men, 
and Non-ill Controls 
n=25 male Vietnam 
combat veterans with 
PTSD, n=16 male 
patients with Major 
Depressive Disorder, and 
n=10 male control 




R; Mississippi Scale for 
Combat-Related PTSD; 
Hamilton Depression and 
Anxiety Scales; Urine 
drug screen; 
Polysomnography 
Sleep lab study. PTSD and 
MD groups were tapered off 
medications for at least two 
weeks prior to study. Urine 
drug screens were given 
within two weeks of sleep 
recording. All participants 
were habituated to 
conventional sleep-wake 
schedules. Participants spent 
2 nights in the laboratory with 
measurements done on the 
second night of sleep. Patients 
were monitored with EEG, 
EMG, EOG, EKG, and 
oximetry and respiratory-
strain gauge monitors.  
 
Analyses: t-tests, ANOVA, 
ANCOVA, Pearson 
correlations 
 Veterans with chronic PTSD showed 
impairment in maintaining sleep when 
compared to clinical and non-clinical 
samples. Percentages of REM and 




Ashlock, L., & 
Nolan, B. 1995 
Sleep Events Among 
Veterans with Combat-
related Posttraumatic 
Stress Disorder (Sleep 
Survey) 
n=58 male Vietnam 
combat veterans (n=37 
with PTSD) not in 
treatment 




developed survey (sleep 
disruption and adaptation 
during combat tours, 
current sleep habits and 
symptoms)  
Veterans recruited from two 
outpatient settings and one 
community setting. Veterans 
screened for combat exposure 
by review of military 
discharge forms and interview 
(outpatient veterans only). 
 
Analyses: Chi-square 
 Combat veterans with PTSD reported 
significantly fewer hours of sleep than 
combat veterans without PTSD.  
 Insomnia and nonrestorative sleep 
were endorsed as significant problems 
by 59-73% of PTSD group compared 
with 19-38% of non-PTSD group.  
 Awakening in the middle of the night 
was most commonly endorsed by 
PTSD veterans with noncombat 
nightmares, combat nightmares, 
thrashing movements during sleep, 





AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Mellman, T., 
Kulick-Bell, R., 
Ashlock, L., & 
Nolan, B. 1995 
Sleep Events Among 
Veterans with Combat-
related Posttraumatic 
Stress Disorder (Sleep 
Diary) 
 n=52 male Vietnam 
combat veterans in 
inpatient PTSD treatment 
Structured Clinical 
Interview for DSM-III 
PTSD Section; 




Veterans completed sleep 
diaries on three consecutive 
mornings regarding the 
previous night's sleep during 
the 3rd or 4th week of a 





 PTSD symptom severity and average 
nightly frequency of types of 
awakening were not associated.  
 Veterans documented an average of 
2.5 awakenings per night 
characterized by nightmares related to 
combat themes, dreams with other 
distressing content, startle or fear 
awakening with no dream recall, and 
panic awakenings. 
Mellman, T., 
Kulich-Bell, R., Ash 
lock, L., & Nolan, 
B. 1995 
Sleep Events Among 
Veterans with Combat-
related Posttraumatic 
Stress Disorder (Sleep 
Laboratory)  
n=21 male Vietnam 
combat veterans with 
PTSD and n=8 healthy 
male comparison subjects 
not exposed to combat 
EEG, EGG, EGG leads, 
goniometry and 
respiratory strain gauge 
monitors; electro-
oculograph 
Veterans spent 2 consecutive 
nights in the sleep laboratory 
with data taken the second 
night. Veterans filled out a 
sleep diary following the 
sleep monitoring.  
 
Analyses: MANOVA, t-tests 
 Among veterans with PTSD, there 
was significantly less sleep efficiency, 
significantly greater amount of time 
awake during sleep, and significantly 
more micro-awakenings.  
 28.6% of PTSD vs. 0% of controls 
had body movement and 33.3% of 
PTSD vs. 0% of controls had periodic 
limb movement.  
Neylan, T. C., 
Marmar, C. R., 
Metzler, T. J., 
Weiss, D. S., 
Zatzick, D. F., 
Delucchi, K. L., 
Wu, R. M., & 
Schoenfeld, F. B.  
1998 
Sleep Disturbance in the 
Vietnam Generation: 
Findings from a 
Nationally 
Representative Sample 
of Male Vietnam 
Veterans 
n=1200 male Vietnam 
theatre veterans, n=412 
male Vietnam era 
veterans, n=450 male 
civilian comparison 
subjects 
Mississippi Scale for 
Combat-Related 
Posttraumatic Stress 
Disorder (military and 
civilian version); DIS; 
medical condition 
questions taken from the 
National Survey of the 
Vietnam Generation   
Correlational study and 
retrospective review of the 
data from the National 
Vietnam Veterans 
Readjustment Study. Sleep 
items derived from the 
Mississippi Scale for Combat-
Related PTSD.  
 
Analyses: Pearson correlation 
 Frequent nightmares were unique to 
veterans diagnosed with PTSD.  
 Combat exposure was highly 
associated with nightmares, 
moderately associated with sleep 
onset insomnia, and only weakly 
associated with sleep maintenance 
insomnia.  
 A strong relationship was noted 
between frequency of nightmares  and 
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Raskind, M. A., 
Peskind, E. R., 
Hoff, D. J., & Hart, 
K. L. 2007 
A Parallel Group 
Placebo Controlled 
Study of Prazosin for 
Trauma Nightmares and 
Sleep Disturbance in 
Combat Veterans with 
Post-traumatic Stress 
Disorder 
n=40 veterans who have 
frequent and severe 





Depression Rating Scale; 
Clinical Global 
Impression of Change; 
Pittsburgh Sleep Quality 
Index 
Diagnosis of PTSD based on 
the results of CAPS score. 
Prazosin or placebo capsules 
were administered using a 
stratified permuted block 
randomization procedure and 
titrated upward by the 
prescriber based on clinical 
response. Goal was  complete 
absence of trauma 
nightmares. Systolic and 
diastolic blood pressure were 
measured at baseline, each 
titration visit and at 
maintenance dose weeks 4 
and 8. Adverse events were 
monitored at baseline and at 
each subsequent visit.  
 
Analyses: Odds ratio, 
confidence intervals, 
regression analyses.  
 Prazosin produced significantly 
greater improvement than placebo in 
addressing frequency and intensity of 
trauma-related nightmares, sleep 
quality, and global clinical status by 
the 8 week follow up.  
 Prazosin reduced military trauma-
related nightmares compared to 
nightmares of any kind and shifted 
dream characteristics from those 
typical of trauma nightmares toward 
those of typical normal dreams.  
 Looked at distressing dreams, sleep 
quality, and dream characteristics.  
Roszell, D. K., 
McFall, M. E., & 
Malas, K. L. 1991 
Frequency of Symptoms 
and Concurrent 
Psychiatric Disorder in 
Vietnam Veterans with 
Chronic PTSD 
n=116 male Vietnam 
veterans referred for 
PTSD evaluation 
SCID-P 
n=48 had 4-6 hours of 
clinical interviewing to assess 
for military history and DSM-
III-R Axis I mental disorders 
using SCID-P. n=68 only 
administered the PTSD 
portion of the SCID-P  
 
Analyses: correlations 
 39.2% of veterans avoided sleep 
because they anticipated troubling 
thoughts or dreams.  
 Mean number of hours of sleep per 
night was 4.4 +_1.3.  
 Symptoms of reexperiencing were 
significantly related to symptoms of 
avoidance or numbing and 
physiological arousal.  
 Sleep difficulties were diagnosed in 
90.5% of veterans.  
Stein, M. B., Kline, 









veterans with PTSD 
Clinician Administered 
PTSD Scale; Center for 
Epidemiological Studies 
Depression Scale; 
Pittsburgh Sleep Quality 
Index 
Psychopharmaceutical study. 
Veterans continued taking a 
stable dose of SSRIs 
throughout the study. 
Veterans were assigned to 
Olazapine or placebo group 
for 12 weeks.  
 
Analyses: t-test 
 Olanzapine was associated with 
significantly greater reduction than 
placebo in sleep disturbance.  
 Change in sleep disturbance was 
moderately correlated with change in 
PTSD symptoms, suggesting that 
enhanced sleep accounts for much of 






AUTHORS STUDY PARTICIPANTS INSTRUMENTS METHODS RESULTS 
Woodward, S. H., 
Arsenault, N. J, 
Murray, C.,  & 
Bliwise, D. L. 2000 
Laboratory Sleep 
Correlates of Nightmare 
Complaint in PTSD 
Inpatients 
n=63 inpatient veterans 
with PTSD 
Clinician-Administered 
PTSD Scale (n=58); 
Structured Clinical 






Sleep laboratory study. CAPS 
and SCID were administered 
to determine PTSD diagnosis. 
Veterans spent 3 or 4 nights 
in the sleep laboratory and 
made entries into sleep diaries 
before and after sleep as well 




MANOVA, chi-square tests 
 Trauma-related nightmares were 
associated with increased wake-after-
sleep-onset, whereas non-trauma 
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 Current research has demonstrated that mortality rates due to preventable behavioral causes 
are significantly higher among veterans diagnosed with posttraumatic stress disorder (PTSD) 
than in the general population. In particular, veterans diagnosed with chronic PTSD die more 
frequently from conditions related to substance abuse, such as Hepatitis C, blood diseases, 
violence, aggression, and suicide (Drescher, Rosen, Burling, & Foy, 2003; Schafer, 2008). In 
addition, rates of behaviorally-related diseases such as obesity, diabetes, and heart disease are 
high among veterans diagnosed with chronic PTSD (David, 2004; Kubzansky, Koenen, Spiro, 
Vokonas, & Sparrow, 2007). These findings highlight a need to promote healthy behavioral 
practices among veterans diagnosed with PTSD. In light of this need, the developers created a 
manualized group treatment designed to decrease health risk behaviors and promote positive 
health practices among veterans diagnosed with PTSD.  
 Research has shown that motivational interviewing is effective at reducing alcohol use, 
drug use, cigarette smoking, and risky sexual practices among adult populations (Ball et al., 
2006; Bellack, Bennett, Gearon, Brown, & Yang, 2006; Butler et al., 1999; Carroll et al., 2005). 
Although the research is limited among veteran populations, studies examining the efficacy of 
motivational interviewing in various behavioral domains suggest its efficacy extends to the 
veteran population (Davis, Baer, Saxon, & Kivlahan, 2003; Project MATCH Research Group, 
1997).  In light of the success of motivational interviewing in promoting behavioral change, this 
intervention incorporates motivational interviewing strategies to increase veterans’ awareness 
of engagement in health risk behaviors and increase their motivation to change. To the 
developer’s knowledge, there is currently no standardized, motivational interviewing treatment 




 The Live Long and Prosper group treatment is comprised of a three-piece manual set 
that includes a Facilitator’s Guide, Member Workbook, and Assessment Strategy. The 
Assessment Strategy is an integral component of the motivational interviewing protocol and is 
designed to offer a means to comprehensively and systematically assess veteran engagement in 
health risk behaviors as well as assess veteran motivation for change. Motivational interviewing 
exercises included in the Live Long and Prosper group protocol foster consideration of personal 
values and goals and promote exploration of the dissonance between these values and goals 
and the group participant’s current behavior. Assessment instruments strategically placed 
within the intervention offer objective data to the group participants which can be used for 
further reflection and exploration of their current level of engagement in health risk behaviors, 
current motivation to change, and how these correspond with their personal values, interests, 
and goals.  
 The integrated assessments also provide useful information to the group facilitators 
about the needs of the group members as well as the efficacy of the intervention. Furthermore, 
the assessment strategy provides a comprehensive blueprint for empirical validation of the 
group treatment. Pre- and post-intervention measures are included which allow for comparison 
of behavioral engagement and motivation for change before and following the intervention. In 
addition, pre- and post- session measures of motivation for change are included, which allow for 
validation of the efficacy of the intervention for each session. Included within the assessment 
strategy is a schedule for test administration to facilitate ease of evaluation and promote 
consistency among research studies.  Alternative test administration schedules are also included 





 The assessment strategy includes assessments in five domains: (a) frequency of veteran 
engagement in health risk behaviors pre- and post- intervention, (b) veteran readiness to 
change pre- and post- intervention, (c) veteran engagement in session specific health risk 
behaviors, (d) veteran readiness to change heath risk behaviors pre- and post- session, and (e) 
facilitator adherence to the treatment protocol. During the initial group session, all group 
participants are administered a comprehensive self-report measure assessing the frequency of 
their engagement in all relevant health risk behaviors and a readiness to change measure 
assessing their current stage of change for health related behaviors, attitudes, and practices. 
These measures will be re-administered at completion of the treatment to monitor changes in 
these domains. Each session, veterans will complete pre- and post-session readiness to change 
measures specifically related to the session content and session specific measures of behavioral 
frequency. Facilitators will complete assessments following each session that are designed to 
enhance facilitator adherence to the group treatment.   
Development of Assessment Measures 
The development of the assessment measures was informed by research and existing 
assessment instruments. Initially, assessment measures utilized in existing group treatments 
were reviewed. Of particular note were assessments included in Trauma Focus Group Therapy 
(Foy, Ruzek, Glynn, Riney, & Gusman, 2002),Trauma and Spirituality Group (Leoni, 2005; 
Romesser, 2005; Sornborger, 2005), Group Treatment for Substance Abuse: A Stages-of-Change 
Therapy Manual (Velasquez, Maurer, Crouch, & DiClemente, 2001), and Curriculum-Based 
Motivation Group: A Five Session Motivational Interviewing Group Intervention (Fields, 2004). In 
addition, behavioral frequency and stages of change measures available on the internet for diet, 




numerous websites, specifically the National Institute of Health, Centers for Disease Control and 
Prevention, US Department of Health and Human Services, American College of Sports 
Medicine, National Institute on Aging, United States Department of Agriculture, and the Cancer 
Prevention Research Center informed the assessment measures created by the developers. In 
addition, components of the High-Risk Behavior Questionnaire (Ruzek et al., 2000) were 
adapted to inform session specific measures of behavioral frequency and motivation to change. 
Research was also undertaken to determine the most common measures of behavioral 
frequency used to assess substance use and smoking in research done within the veteran 
population. Those measures that appeared with the most frequency in the literature were 
identified, their ease of usability was ensured, and they were integrated into the assessment 
strategy.  In addition, the Facilitator’s Adherence Checklist was adapted from the Trauma and 
Spirituality group protocol (Romesser, 2005) to meet the needs of the current intervention.  
Live Long and Prosper Assessment Measures 
Measures of Behavioral Frequency 
 Pre-existing measures of the frequency of engagement in health risk behaviors as well 
as developer-created measures of behavioral engagement are included in the assessment 
strategy. Behavioral frequency measures are administered at the commencement of the group 
intervention, at completion of the group intervention, and during each session.  
 Health Behavior Frequency Measure. The Health Behavior Frequency Measure (HBFM) is 
a developer-created self-report instrument that examines the frequency of engagement in 
health risk behaviors. This measure is administered to the group participants at the beginning of 
the first session of the health promotion group intervention and at the completion of the 




group protocol; specifically, diet, exercise, sleep difficulties, risky sex behavior, aggressive acts, 
substance use, and tobacco use. The measure incorporates questions regarding aggressive acts, 
gun ownership, smoking, and risky sex behavior from the High-Risk Behavior Questionnaire 
(Ruzek et al., 2000), an unpublished measure used in the original Live Long and Prosper group. 
In addition, questions regarding substance use were informed by the structure of questions 
from the High-Risk Behavior Questionnaire, Alcohol Use Disorders Identification Test (Babor, de 
la Fuente, Saunders, & Grant, 1992) and the Drug Use Questionnaire (Skinner, 1982), pre-
existing measures incorporated into the substance use session.  Assessment questions 
pertaining to diet, exercise, and sleep difficulties were informed by reviews of research in these 
areas.  
 The HBFM is a 21-question scale, with answers provided in a Yes-No format or on a 
Likert scale.  The measure allows for the qualitative analysis of veteran’s engagement in a 
variety of health risk behaviors that are found with great frequency among veterans diagnosed 
with PTSD and lead to increased mortality in this population. This measure is designed to 
provide information to the group facilitator about the frequency of veteran engagement in each 
behavioral domain at the onset of the group, which allows for the facilitator to address the 
needs of individual veterans, as well as illuminate changes in frequency of engagement in risky 
behaviors when administered post-intervention. As the measure is administered pre- and post-
intervention, it allows for empirical validation of the intervention based on changes noted in 
veteran engagement in health risk behaviors. 
 Developer-created session specific measures of behavioral frequency. Session-specific 
measures of behavioral frequency are administered during each session. These self-report 




health risk behaviors. These measures promote veteran awareness of their current level of 
behavioral engagement and provide information integral to the motivational interviewing 
exercises included in the group protocol.  
 Following an extensive review of measures assessing diet, heart disease, exercise, sleep, 
and safe sex behavior, the developers determined that the intervention would be best served by 
the creation of new measures specifically designed for the group intervention. The developers 
created five behavioral frequency measures designed to assess eating habits, risk for heart 
disease, exercise, sleep, and safe sex behavior. Each assessment measure was informed by the 
research and follows the recommendations of relevant groups dedicated to prevention of 
disease/health risk in these areas; specifically, the National Institute of Health, Centers for 
Disease Control and Prevention, United States Department of Agriculture, United States 
Department of Health and Human Services, American College of Sports Medicine, and the 
National Institute on Aging.  
 The self-report measures of behavioral frequency are presented in a variety of formats. 
Veterans are asked to respond using a Yes-No format, Likert scale, or by checking off individual 
boxes. Scoring is included for each measure and is designed to be user friendly. It provides 
pertinent information that can be easily disseminated to the veterans orally by the group 
facilitators. The information provided in the scoring components is designed to elicit 
consideration by the veterans of their current level of engagement in health risk behaviors and 
offers suggestions for behavioral change.  
 Aggressive Behavior Questionnaire and Firearm Safety Questionnaire. The Aggressive 
Behavior Questionnaire and the Firearm Safety Questionnaire were created from the High-Risk 




questions measuring veteran engagement in aggressive behaviors and firearm safety to create 
comprehensive measures.  
 The Aggressive Behavior Questionnaire is an 8-item self-report measure of aggressive 
behavior. Specifically, the measure assesses engagement in verbal threats, assault, property 
damage, and aggressive driving within the last year. Veterans are also asked to rate their 
frequency of engagement in any aggressive behavior in the last year on a Likert scale. The 
Firearm Safety Questionnaire is a 7-item self-report measure. It assesses whether firearms are 
kept according to National Rifle Association safety guidelines and personal risks factors for 
unsafe gun use, such as previous suicide attempt with a firearm or previous discharge of a 
weapon outside of military or law enforcement service.  Veterans are asked to answer questions 
about firearm safety in a Yes-No format. The measures are administered concurrently during 
Session 7: Aggressive Behavior/Gun Safety.  
 Alcohol Use Disorders Identification Test (Babor, de la Fuente, Saunders, & Grant, 1992). 
The Alcohol Use Disorder Identification Test (AUDIT) is a 10-question measure of alcohol use 
scored on a 5-point Likert scale. It was developed by the World Health Organization as a brief 
screening tool for excessive drinking. It is frequently used in the assessment of drinking behavior 
in research pertaining to veterans. The AUDIT provides an accurate risk assessment for 
hazardous or harmful alcohol use or alcohol dependence across cultures, gender, and age 
(Babor, Higgins-Biddle, Saunders, & Monteiro, 2001). Research has shown the AUDIT to have 
favorable sensitivity (.90) and lower but still acceptable specificity (.80) for current ICD-9 alcohol 
use disorders when using the cut-off score of 8 (Babor et al.), the cutoff score used in this 
assessment strategy. Research has also shown the AUDIT to have high internal consistency and 




 The AUDIT was created for primary care workers to identify those who would benefit 
from reducing their level of alcohol consumption and to provide a framework for intervention 
among this population. These intentions are in line with the rationale for the current manual set 
targeting health risk behaviors and promoting motivation to change substance use habits. In the 
current group protocol, the AUDIT is administered during the Substance Use session to increase 
veteran’s awareness of their current drinking habits.  
 Drug Use Questionnaire, Short Form (Skinner, 1982). The Drug Use Questionnaire, Short 
Form (DAST-10) is a 10-item self-report instrument designed for brief clinical screening and 
treatment evaluation research to determine psychoactive drug abuse (Gavin, Ross, & Skinner, 
1989). Veterans are asked to note “yes” or “no” to questions regarding their engagement in 
drug use over the past 12 months. Research studies have found that the DAST has high levels of 
internal consistency reliability (0.92), a largely unidimensional scale, and concurrent validity with 
frequency of drug use in the last 12 months (Skinner, 1982).  At a cut-off point between 5/6 and 
9/10, the DAST shows sensitivity between 96% to 78% and specificity between 79% and 89% 
with overall accuracy of 85% (Gavin, Ross, & Skinner). The DAST is also highly correlated with 
current (r=0.75) and lifetime (r=0.74) DSM-III drug diagnosis (Gavin, Ross, & Skinner).  
 The DAST-10 is administered during the Substance Use session of the group intervention 
along with the AUDIT. The developers chose to administer the DAST-10, the short form of the 
DAST, rather than the DAST to avoid fatiguing the group participants as multiple measures of 
behavioral frequency are administered during this session. In the current group protocol, the 
DAST-10 is administered during the Substance Use session to increase veteran’s awareness of 




 Fagerström Test for Nicotine Dependence. (Heatherton, Kozlowski, Frecker, & 
Fagerström, 1991). The Fagerström Test for Nicotine Dependence (FTND) is a 6-item self-report 
instrument designed to assess for level of nicotine dependence. Specifically, it assesses smoking 
frequency and habits. The FTND has been tested for reliability and validity among a psychiatric 
population and a population of veterans with PTSD (Buckley et al., 2005). Among these 
populations, the FTND was found to be stable based on test-retest reliability (0.82) and was 
correlated at statistically significant levels with biological and psychological measures of 
dependence (0.40) (Buckley et al.).   
 The FTND is administered to the group participants during the Tobacco Use session. It is 
designed to assist veterans in acknowledging their level of nicotine dependence and to promote 
critical thinking about their tobacco use.   
Stages of Change Measures 
 Developer-created stages of change measures are included in the assessment strategy. 
Stage of change is measured pre- and post- intervention as well as pre- and post- session.  The 
developers performed a comprehensive review of existing stages of change measures including 
the University of Rhode Island Change Assessment Scale (DiClemente & Hughes, 1990), stages of 
change measures utilized in research studies, stages of change measures included in other 
group protocols, and stages of change measures for health risk behaviors from the Cancer 
Prevention Research Center. As the stages of change measures found did not meet the exact 
needs of the current group protocol, the developers created new measures informed by their 
research and containing the most salient aspects of measurement of stages of change found 




 Health Risk Stages of Change Measure. The pre- and post- intervention Health Risk 
Stages of Change measure was designed to assess the group participants’ current stage of 
change related to any behaviors in which they currently engage that may have a negative impact 
on their health. Although the group participants are encouraged to reflect upon those behaviors 
included in the group protocol, specific measures of stage of change for individual health risk 
behaviors are not included.   
 The measure assesses the group participants current stage of change by having the 
group participants first select one of six statements pertaining to their health related behaviors 
and then circling the stage of change that corresponds to the original statement selected. By 
separating the statement which best reflects their current health related behavior and the 
related stage of change, the developers hope to decrease judgment and promote honest 
disclosure of health risk behavior engagement.  
 The pre- and post- intervention Health Risk Stages of Change Measure is designed to 
fulfill several functions. The pre- and post- intervention design offers a format for collecting 
empirical data about the efficacy of the group protocol to increase group participants’ 
motivation to change health risk behaviors over the course of the intervention. It also offers the 
group participants objective data on changes in their own motivation for change before and 
following the intervention. In addition, the pre-intervention measure is placed within the first 
session of the group protocol and is used to educate the group participants about the 
transtheoretical model and to familiarize them with the type of measure they will be asked to 
complete each week.  
 Session specific stages of change measures. The group protocol includes seven session 




participant is asked to first select one of six statements pertaining to their session specific health 
related behaviors and then circle the stage of change the corresponds to the original statement 
selected. As with the pre- and post- intervention Health Risk Stages of Change Measure, the 
session specific measures separate the statement which best reflects the group participant’s 
current health related behavior and the related stage of change to decrease judgment and 
promote honest disclosure of health risk behavior engagement.  
 The session specific stages of change measures are intended to perform multiple 
functions. First, they are designed to increase the group participants’ awareness of their current 
level of motivation for change, promote critical thinking about their own motivations, and 
illuminate any changes in motivation following the group session. In addition, the pre- and post- 
session design allows for empirical evaluation of the efficacy of the individual group sessions to 
motivate change in health risk behaviors.   
Facilitator’s Adherence Checklist 
 Following each session, the facilitators will complete a session-specific Faclitator’s 
Adherence Checklist. The Facilitator’s Adherence Checklist was adapted from the Adherence 
Checklist (Romesser, 2005) found in the Trauma and Spirituality Group (Romesser, 2005; 
Sornborger, 2005; Leoni, 2005). In the Facilitator’s Adherence Checklist, the major components 
of each session are identified and the facilitators are asked to check off the completed 
components. Additional space is provided so the facilitators may note areas of difficulty, 
obstacles to completion, or issues of relevance for each session component.  The Facilitator’s 
Adherence Checklist allows for assessment of fidelity to the protocol. It also serves as a means 
of identifying problem areas, obstacles to successful session protocol completion, and areas for 





This schedule provides a list of the assessment measures and the session in which they are administered to 
the group participants. For appropriate placement of the measures in each session, please refer to the Live 
Long and Prosper Facilitator’s Manual.  
 
Session 1: Group Orientation 
_______ Health Risk Stages of Change Measure    
_______ Health Behavior Frequency Measure 
_______ Facilitator’s Adherence Checklist 
Session 2: Cardiovascular Disease/Physical Activity 
_______ Physical Activity Stages of Change Measure 
_______ Heart Disease and Exercise Questionnaire 
_______ Facilitator’s Adherence Checklist 
Session 3: Obesity/Diabetes/Diet 
_______ Healthy Diet Stages of Change Measure 
_______ Eating Habits Questionnaire 
_______ Facilitator’s Adherence Checklist 
Session 4: Sexually Transmitted Diseases 
_______ Safe Sex Practices Stages of Change Measure 
_______ Safe Sex Behavior Questionnaire 
_______ Facilitator’s Adherence Checklist 
Session 5: Substance Abuse 
_______ Alcohol Abuse Stages of Change Measure 
_______ Drug Abuse Stages of Change Measure 
_______ Alcohol Use Disorders Identification Test 
_______ Drug Use Questionnaire, Short Form 
_______ Facilitator’s Adherence Checklist 
Session 6: Tobacco Use 
_______ Tobacco Use Stages of Change Measure 
_______ Fagerström Test for Nicotine Dependence 
_______ Facilitator’s Adherence Checklist 
Session 7: Aggressive Behavior/Gun Safety 
_______ Aggression Stages of Change Measure 
_______ Gun Safety Stages of Change Measure 
_______Aggressive Behavior Questionnaire 
_______ Firearm Safety Questionnaire 
_______ Facilitator’s Adherence Checklist 
Session 8: Sleep Hygiene 
_______ Sleep Hygiene Stages of Change Measure 
_______ Sleep Questionnaire 
_______ Health Risk Stages of Change Measure    
_______ Health Behavior Frequency Measure 




Abridged Administration Schedule 
 
The abridged assessment schedule offers alternative options for administering assessment measures during 
the group intervention. These alternatives are designed for those facilities that do not have the resources to 




The group facilitators may administer the assessment measures as indicated, leaving out the second 
administration of the session specific Stages of Change measures. This option maintains the integrity of the 
intervention, capitalizing on the information gleaned from the session specific Stages of Change measures 
administered at the beginning of each session during the MI exercises while saving time and decreasing the 
likelihood group participant burnout on assessment measures. All measures of health risk behavior 
frequency should be administered as outlined on the Assessment Schedule. In addition, the facilitators 
should complete the session specific Facilitators Adherence Checklist to ensure fidelity to the treatment 
protocol and identify any obstacles and areas of strength or weakness.  
 
 
Option 2:  
The group facilitators may omit all session specific Stages of Change measures in sessions 2-8; however, 
the administration of the Health Risk Stages of Change measure in Session 1 and 8 should be maintained. 
The administration of this measure will allow the group facilitators and participants to reflect on any changes 
in participant motivation to change health risk behaviors from the beginning to the end of the intervention. 
Rather than completing the session-specific stages of change measures, the group participants should be 
asked to reflect on their current stage of change related to each session-specific health risk behavior during 
the MI exercises. The group facilitators may wish to provide a generic Stages of Change model graph (e.g. 
an image of a staircase with the lowest step labeled precontemplation and the highest step labeled 
maintenance) on posterboard or on a whiteboard to which group participants can refer throughout the 
session. All measures of health risk behavior frequency should be administered as outlined on the 
assessment schedule. In addition, the facilitators should complete the session specific Facilitators 
Adherence Checklist to ensure fidelity to the treatment protocol and identify any obstacles and areas of 











Measures included:  
Health Risk Stages of Change Measure 
Health Behavior Frequency Measure 




Health Risk Stages of Change Measure 
This group seeks to inform you about behaviors that can negatively impact your long 
term health and longevity. It will increase your knowledge in these areas, increase your 
awareness of the frequency of your own participation in these behaviors, and perhaps 
motivate you to take steps towards changing some of these behaviors.   
This measure is designed to help you and your group facilitators assess your current 
thoughts about changing health-risk behaviors. You will complete a similar measure 
during each session in reference to the specific session topic.  
Please take a moment to consider any current behavior in which you engage that may 
have a negative impact on your health. In particular, take time to reflect on the 
following: your diet, level of engagement in exercise, sleep problems, substance use, 
smoking, unsafe sex practices, level of aggression, and gun safety.   
 
Please circle the number that best fits your current health related behavior:  
1. I have been engaging in behavior that has positive health impacts regularly for 
over 6 months.  
 
2. I have been engaging in behavior that has positive health impacts for less than 6 
months.  
 
3. I plan to begin to engage in behavior that has positive health impacts in the next 
30 days.   
 
4. I plan to begin to engage in behavior that has positive health impacts in the next 
6 months.  
 
5. I have no plans to begin engaging in behaviors that have positive health impacts.  
 









Please circle your current stage of change that corresponds to the the number circled 
above.   
1. I have been engaging in behavior that has positive health impacts regularly for a 
long time. I am using strategies to continue this behavior. I am in the 
MAINTENANCE stage.  
2. I have been engaging in behavior that has positive health impacts. I am taking 
steps to avoid pitfalls or obstacles to my engagement in these positive behaviors.  
I am in the ACTION stage.  
3. I am seriously considering beginning to engage in behavior that has positive 
health impacts.  I can see the benefits these behaviors and have a plan to start. I 
am in the PREPARATION stage.  
4. I am considering the possibility of engaging in behaviors that have positive health 
impacts, but remain unsure.  I may be trying small changes. I am in the 
CONTEMPLATION stage.  
5. I do not want to change my behavior to engage in those with positive health 
impacts. I am in the PRECONTEMPLATION stage.  
6. I have always engaged in behavior that has positive health impacts. The stages of 






Health Behavior Frequency Measure 
This measure is designed to help determine your current engagement in a variety of 
different behaviors that can impact on your health. Please circle the response that best 
fits your current level of engagement in these behaviors. Please be as honest as 
possible.  
1) How often do you incorporate these foods into your diet? Please circle the response that 
best describes your diet.  





















(e.g. chicken or fish 







Whole Grains  









2) How often do you engage in: 
a) Light intensity activities (e.g. casual walking, taking out the trash) per week? 
   Never    1 time  2 times  3 times  4 times   5 or more  
               
b) Moderate intensity activities (e.g. brisk walking) per week?  
   Never    1 time  2 times  3 times  4 times   5 or more 
              
c) Vigorous intensity activities (e.g. jogging, swimming laps) per week?  
   Never    1 time  2 times  3 times  4 times   5 or more  
               
d) Strengthening activities (e.g. sit-ups, weight lifting) per week?  
   Never    1 time  2 times  3 times  4 times   5 or more  





3) Do you have difficulty falling or staying asleep?  
    Yes    No 
4) On average, how many hours of sleep do you get each night? _______________ 
5) Have you ever been tested for HIV or Hepatitis C?  
    Yes    No 
6) Have you engaged in unprotected sex (i.e. oral, anal, or vaginal sex without a condom)?  
                Yes    No 
7) If so, how frequently do you engage in unprotected sex?  
   Almost Never  Sometimes  Almost Always  Every time  
8) Have you made verbal threats to others?  
    Yes    No 
    If so, how often?  
   Rarely   Sometimes  Very Regularly 
9) Have you assaulted others?  
    Yes    No 
    If so, how often?  
 Rarely   Sometimes  Very Regularly 
10) Have you intentionally damaged property?  
    Yes    No 
   If so, how often?  
 Rarely   Sometimes  Very Regularly 
11) Have you engaged in aggressive driving (e.g. verbal outbursts, angry hand gestures, 
tailgating, driving under the influence, intentionally driving your vehicle into another object?)  
   Yes    No 
If so, how often?  




12) Do you own firearms?  
   Yes    No 
13) If you own a firearm, do you keep all of your firearms in a safe manner (e.g. unloaded, in a 
locked area with protected locks and the bullets separate from the firearms)? 
 Yes    No 
14) Do you drink alcohol?  
 Yes    No 
15) If you drink alcohol, how often do you have a drink?  
 Monthly or less     2-4 times a month  2-3 times a week        4 or more times a week  
 
16) On a typical day, how many drinks do you have?  
 1 or 2  3 or 4       5 or 6          7 to 9        10 or more 
 
17) How often do you have 6 or more drinks on one occasion?  
 Never        Less than monthly    Monthly Weekly  Daily or almost daily 
 
18) Have you used drugs other than those required for medical reasons (e.g. abuse of 
prescription medication or illegal drugs)?  
 Yes   No  
19) If you use drugs, how often do you use them?  
Monthly or less      2-4 times a month  2-3 times a week       4 or more times a week 
20) Do you smoke cigarettes?  
 Yes    No 
21) How many cigarettes do you smoke per day?  
 10 or less 11-20     21-30      31 or more 
 
 




Facilitator’s Adherence Checklist: Group Orientation 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Health Behavior Frequency Measure 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction to the group 
________________________________________________________________________ 
________________________________________________________________________ 
 Review group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation on PTSD and health risk behavior/conditions 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of member workbook and overview of session topics 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of stages of change model 
________________________________________________________________________ 
________________________________________________________________________ 






 Personal values exercise 
________________________________________________________________________ 
________________________________________________________________________ 
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Session 2:  






Measures included:  
Physical Activity Stages of Change Measure 
Heart Disease and Exercise Questionnaire 






Physical Activity Stages of Change Measure 
For the purpose of this measure, REGULAR EXERCISE is defined as 30 minutes of 
moderate physical activity at least five days per week. Examples of moderate physical 
activity include walking briskly, mowing the lawn, dancing, swimming or bicycling. 
Please check the box that best fits your current exercise behavior:  
1. I have been exercising regularly for over 6 months.  
2. I have been exercising regularly for less than 6 months. 
3. I plan to begin to exercise regularly in the next 30 days.  
4. I plan to begin to exercise regularly in the next 6 months.  
5. I have no plans to begin exercising regularly.  
6. I have always exercised regularly. 
Please circle your current stage of change corresponding to the number circled above.   
1. I have been exercising regularly for a long time. I am using strategies to continue 
this behavior. I am in the MAINTENANCE stage.  
2. I have been exercising regularly. I am taking steps to avoid pitfalls or obstacles to 
exercise.  I am in the ACTION stage.  
3. I am seriously considering beginning to exercise regularly.  I can see the benefits 
of exercise and have a plan to start. I am in the PREPARATION stage.  
4. I am considering the possibility of exercising regularly, but remain unsure.  I may 
be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not want to exercise regularly. I am in the PRECONTEMPLATION stage.  






Heart Disease and Exercise Questionnaire 
1) Please check those items which pertain to your current health status:  
 High Cholesterol  Diabetes  Obesity  
 High blood pressure  Smoking  Family History of Heart Disease 
 
2) How often do you engage in light intensity (e.g. casual walking, taking out the trash) physical 
activity each week?  
 Never 1 time  2 times  3 times      4 times  5 or more times 
  a week  a week  a week  a week  a week 
 
In general, how many minutes do you spend doing these activities on each occasion?______ 
 
3) How often do you engage in moderate intensity (e.g. brisk walking, activities that cause you 
to break a sweat) physical activity each week?  
 Never 1 time  2 times  3 times      4 times  5 or more times 
  a week  a week  a week  a week  a week 
 
In general, how many minutes do you spend doing these activities on each occasion?______ 
 
4) How often do you engage in vigorous intensity (e.g. jogging, swimming laps, heavy 
gardening) physical activity each week?  
 Never 1 time  2 times  3 times      4 times  5 or more times 
  a week  a week  a week  a week  a week 
 
In general, how many minutes do you spend doing these activities on each occasion?______ 
 
5) How often do you do muscle strengthening exercises (e.g. lifting weights, doing sit-ups, 
shoveling) each week?  
 Never 1 time  2 times  3 times      4 times  5 or more times 
  a week  a week  a week  a week  a week 
 
In general, how many repetitions of these exercises do you do?  _______________________ 
In general, what muscle groups are involved in these exercises? (check all that apply) 
 Legs    Abdomen  Hips  Back   




Heart Disease and Exercise Questionnaire Scoring 
 
Heart Disease 
Look at Question 1. If any box is checked, you are at risk for developing heart disease.  
The more boxes checked, the higher the risk.  
 
Exercise 
If you circled any engagement in exercise on Questions 2-5, CONGRATULATIONS! You 
are already engaging in physical activity. However, you may need to increase your level 
of physical activity to include moderate and vigorous activities, strength exercises, or 
increase exercise duration in order to reap the most benefits for your health.  Look at 
the chart below to see how you measure up.  
The amount of physical activity recommended by the NIH, AHA, and the ACSM to 
receive health benefits is: 
30 minutes of moderate intensity exercise 
5 times a week 
OR 
20 minutes of vigorous exercise 
3 times a week 
AND 
8-12 repetitions of a muscle strengthening exercise 
2 times a week 
Involving all major muscle groups 
Exercise duration can be broken up into 10 minute periods throughout the day. 





Facilitator’s Adherence Checklist: Cardiovascular/Exercise Session 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of Heart Disease and Exercise Questionnaire 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about heart disease and exercise 
________________________________________________________________________ 
________________________________________________________________________ 






 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
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Measures Included:  
Healthy Diet Stages of Change Measure 
Eating Habits Questionnaire 






Healthy Diet Stages of Change Measure 
For the purpose of this measure, A HEALTHY DIET is defined as incorporating fruits, 
vegetables, low-fat dairy products, lean meats, and whole grains into your daily diet 
and/or abiding by physician recommended dietary restrictions.  
Please check the box that best fits your current eating habits:  
1. I have been eating a healthy diet for over 6 months.  
2. I have been eating a healthy diet for less than 6 months. 
3. I plan to begin to eat a healthy diet in the next 30 days.  
4. I plan to begin to eat a healthy diet in the next 6 months.  
5. I have no plans to begin to eat a healthy diet.  
6. I have always eaten a healthy diet.  
Please circle your current stage of change corresponding to the number circled above.   
1. I have been eating a healthy diet for a long time. I am using strategies to 
continue this behavior. I am in the MAINTENANCE stage.  
2. I have been eating a healthy diet. I am taking steps to avoid pitfalls or obstacles 
to healthy eating.  I am in the ACTION stage.  
3. I am seriously considering a change to a healthy diet.  I can see the benefits of 
healthy eating and have a plan to start. I am in the PREPARATION stage.  
4. I am considering the possibility of changing to a healthy diet, but remain unsure.  
I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not want to eat a healthy diet. I am in the PRECONTEMPLATION stage.  
6. I have always eaten a healthy diet. The stages of change model is not applicable 





Eating Habits Questionnaire  
Please circle the answer which best describes your eating habits.  
1) Have you been diagnosed with diabetes?  
 Yes   No 
      
2) If you have physician recommended dietary restrictions, do you follow these restrictions? 
 Never/Rarely   Sometimes  Daily 
                      
3) How often do you incorporate these foods into your diet? Please circle the response that 
best describes your diet.  





















(e.g. chicken or fish 







Whole Grains  









4) How often do you eat fried food? 
 Never/Rarely    Sometimes   Daily 
            
5)  How often do you eat at a fast-food restaurant? 
             Never/Rarely   Sometimes   Daily 
 
6) In which of these behaviors do you regularly engage? 
 Eating while watching television   Eating quickly 
 Eating while standing up   Overeating 







Eating Habits Questionnaire Scoring 
Question 1: 
If you have been diagnosed with DIABETES, the type of foods that you incorporate into your diet 
may differ from those which are recommended in Question 3. Please refer to the dietary 
guidelines that have been provided by your physician to distinguish if you are following your 
recommended food guidelines.  
Question 2:  
If you are following your physician recommended dietary restrictions DAILY, 
CONGRATULATIONS! You are taking huge steps to benefit your health.  
If you are following your physician recommended dietary restrictions SOMETIMES, 
CONGRATULATIONS! You are attempting to have an impact on your health. However, you may 
need to increase your adherence to these restrictions to achieve the most benefit and avoid 
negative health impacts.  
If you are following your physician recommended dietary restrictions NEVER/RARELY, you need 
to consider the negative impact that your eating habits have on your health and explore the 
obstacles that keep you from changing your habits.  
Question 3:  
Although the recommended daily intake of food groups is different based on your age, gender, 
and activity level, the USDA recommends DAILY intake of: fruits, vegetables, fat-free or low-fat 
milk group foods (e.g. cheese, yogurt, milk), lean or low-fat meat, poultry, or fish, and whole 
grains.  
Look at your questionnaire and determine if you are currently meeting these guidelines. 
Question 4 & 5:  
The USDA recommends that most of your sources of fat come from fish, nuts, and vegetable 
oils. Most Americans get enough of the oil they need from the foods they eat, such as nuts, fish, 
cooking oil, and salad dressing. As such, your intake of fried and fast food should be limited.  
Fried food, particularly those with a batter coating, and fast-food has been shown to be high in 
fat content and can add unnecessary fat to your diet. Too much fat in your diet can lead to 
numerous negative health consequences such as obesity, high blood pressure, high blood 
cholesterol, coronary heart disease, diabetes and some cancers.  
Questions 6:  
Each of the behaviors listed increases the likelihood that you are eating food that is unhealthy, 
that you are eating more food than necessary, and/or  that you are eating without thinking, or 
really savoring, the food that you are eating. If you have checked one or more of these 
behaviors, you may want to consider changing these behaviors in order to promote positive 




Facilitator’s Adherence Checklist: Obesity/Diabetes/Diet Session 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of Eating Habits Questionnaire 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about obesity, diabetes, and diet 
________________________________________________________________________ 
________________________________________________________________________ 






 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
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Measures included:  
Safe Sex Practices Stages of Change Measure 
Safe Sex Behavior Questionnaire 






Safe Sex Practices Stages of Change Measure 
For the purpose of this measure, SAFE SEX PRACTICES are defined as the use of a 
condom each time you engage in sexual activities and having only one sex partner at a 
time.  
Please check the box that best fits your current sexual behavior:  
1. I have been engaging in safe sex practices for over 6 months.  
2. I have been engaging in safe sex practices for less than 6 months. 
3. I plan to begin engaging in safe sex practices in the next 30 days.  
4. I plan to begin to engage in safe sex practices in the next 6 months.  
5. I have no plans to begin practicing safe sex.  
6. I am not sexually active.  
Please circle your current stage of change corresponding to the number circled above. 
1. I have not had unsafe sex in a long time. I am using strategies to prevent unsafe 
sex. I am in the MAINTENANCE stage.  
2. I have stopped having unsafe sex. I am in the ACTION stage.  
3. I am seriously considering implementing safe sex behaviors.  I can see the 
benefits of safe sex. I am in the PREPARATION stage.  
4. I am considering the possibility of changing my unsafe sex practices, but remain 
unsure.  I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my unsafe sex practices are a problem. I am not thinking of 
changing my unsafe sex practices. I am in the PRECONTEMPLATION stage.  





Safe Sex Behavior Questionnaire 
For the purposes of this measure, UNPROTECETED SEX is defined as engaging in sexual activities 
(oral, anal, vaginal) without the use of a condom.  
Please circle that answer that best reflects your sexual practices. Please be as honest as 
possible.  
1) I have never been tested for HIV or Hepatitis C.  
 Yes    No 
 
2) Have you engaged in unprotected sex? 
 Yes    No 
 
3) When you have/had sex, how often do/did you use condoms?  
 Every time   Sometimes   Never 
 
4) Have you/Are you engaged in sex practices with multiple partners?  
 Yes    No 
 
5) Have you used intravenous drugs?  
 Yes    No 
 
6) Do you know the HIV and Hepatitis C status of your sex partner(s)?  
 Yes    No 
 
7) Have you had unprotected sex with a prostitute? 
 Yes    No 
 
8) Do you engage in sexual practices while under the influence of alcohol or illegal drugs? 
 Yes    No 
 
9) Is your sex partner(s) at risk for having HIV or Hepatitis C? For example: Has he/she 
engaged  in unsafe sex practices, used intravenous drugs,  or had sex for drugs or 
money?  









Safe Sex Behavior Questionnaire Scoring 
Question 1:  
If you answered YES to Question 1, CONGRATULATIONS! You have made a big step 
toward practicing safe and responsible sex and you have shown concern for the health 
of yourself and your sexual partner(s).  
If you answered NO to Question 1, you may want to consider the reasons that have kept 
you from being tested for HIV and Hepatitis C as well as the negative outcomes that may 
come from not finding out your disease status. Both HIV and Hepatitis C are found at 
higher rates among veterans with PTSD than among veterans without PTSD or the 
general public. By finding out your disease status, you can be treated, if necessary, 
which increases positive outcomes for your health and longevity. In addition, by finding 
out your disease status, you will be able to practice safe and responsible sex with your 
partner(s).  
Question 2 & 3:  
If you answered NO to Question 2 and EVERYTIME to Question 3, CONGRATULATIONS! 
You are practicing safe sex and are protecting yourself and your partner(s) from HIV, 
Hepatitis C, and other sexually transmitted diseases.  
If you answered SOMETIMES to Question 3, CONGRATULATIONS! You are trying to 
practice safe sex; however, without consistent use of condoms you cannot be protected 
against HIV and Hepatitis C. You may need to evaluate the situations in which you 
practice unsafe sex and consider ways to change your unsafe behavior.  
If you answered NEVER to Question 3, you are not engaging in safe sex practices. You 
may be compromising your health and that of your partner(s) and are at greater risk of 
acquiring HIV and Hepatitis C. You may want to consider the reasons that you choose to 
practice unsafe sex and weigh the potential outcomes of these unsafe practices against 
your reasons for practicing unsafe sex.  
Question 4-9:  
If you answered YES to any of these questions, you are at an increased risk of acquiring 




Facilitator’s Adherence Checklist: STDs Session 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of Safe Sex Behavior Questionnaire 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about safe sex 
________________________________________________________________________ 
________________________________________________________________________ 






 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
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Measures included:  
Alcohol Abuse Stages of Change Measure 
Drug Abuse Stages of Change Measure 
Alcohol Use Disorders Identification Test 
Drug Use Questionnaire, Short Form 








Alcohol Abuse Stages of Change Measure 
For the purpose of this measure, ALCOHOL ABUSE is defined as having three drinks in a 
row.  
Please circle the number of the statement that best fits your current drinking behavior:  
1. I have not abused alcohol for over 6 months.   
2. I have not abused alcohol within the last 6 months. 
3. I plan to stop abusing alcohol in the next 30 days.  
4. I plan to stop abusing alcohol in the next 6 months.  
5. I have no plans to stop abusing alcohol.  
6. I have never abused alcohol.  
Please circle your current stage of change corresponding to the number circled above. 
 
1. I have not abused alcohol in a long time. I am using strategies to prevent relapse. 
I am in the MAINTENANCE stage.  
2. I have quit abusing alcohol. I am taking steps to avoid triggers and seek help 
from others.  I am in the ACTION stage.  
3. I am seriously considering no longer abusing alcohol.  I can see the benefits of 
quitting and have a plan to quit. I am in the PREPARATION stage.  
4. I am considering the possibility of changing my alcohol abuse, but remain 
unsure.  I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my alcohol abuse is a problem. I am not thinking of quitting 
abusing alcohol. I am in the PRECONTEMPLATION stage.  




Drug Abuse Stages of Change Measure 
For the purpose of this measure, DRUG ABUSE is defined as any use of illegal drugs (for 
example: marijuana, heroin, methamphetamines) or any use of prescription drugs other 
than as prescribed. 
Please circle the number of the statement that best fits your current drug use:  
1. I have not abused drugs for over 6 months.  
2. I have stopped abusing drugs within the last 6 months.   
3. I am planning to stop abusing drugs in the next 30 days.  
4. I am thinking about stopping my drug abuse in the next 6 months.  
5. I have no plans to stop abusing drugs.  
6. I have never abused drugs.  
 
Please circle your current stage of change corresponding to the number circled above.   
1. I have not abused drugs in a long time. I am using strategies to prevent relapse. I 
am in the MAINTENANCE stage.  
2. I have stopped abusing drugs. I am taking steps to avoid triggers and seek help 
from others.  I am in the ACTION stage.  
3. I am seriously considering no longer abusing drugs  I can see the benefits of 
quitting and have a plan to quit. I am in the PREPARATION stage.  
4. I am considering the possibility of changing my drug abuse, but remain unsure.  I 
may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my drug abuse is a problem. I am not thinking of quitting abusing 
drugs. I am in the PRECONTEMPLATION stage.  
6. I have never abused drugs. The stages of change model is not applicable to me. 
46 
 
Alcohol Use Disorders Identification Test (AUDIT) 
Place an X in the one box that best describes your answer to each question. (One drink is equal to 
one can, glass, or bottle of beer, one shot of liquor or one mixed drink, or one glass of wine.) 
 
Questions 0 1 2 3 4  








4 or more 
times a week 
 
2. How many drinks containing 
alcohol do you have on a typical 
day when you are drinking? 
1 or 2 3 or 4 5 or 6 7 to 9 10 or more  
3. How often do you have six or 
more drinks on one occasion? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
 
4. How often during the last year 
have you found that you were 
not able to stop drinking once 
you had started? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
 
5. How often during the last year 
have you failed to do what was 
normally expected of you 
because of drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
 
6. How often during the last year 
have you needed a first drink in 
the morning to get yourself going 
after a heavy drinking session? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
 
7. How often during the last year 
have you had a feeling of guilt or 
remorse after drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
 
8. How often during the last year 
have you been unable to 
remember what happened the 
night before because of your 
drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
 
9. Have you or someone else 
been injured because of your 
drinking? 
No  Yes, but 
not in the 
last year 
 Yes, during 
the last year 
 
10. Has a relative, friend, doctor, 
or other health care worker been 
concerned about your drinking or 
suggested you cut down? 
No  Yes, but 
not in the 
last year 
 Yes, during 




    TOTAL  
 
Each response is scored using the numbers at the top of each column. After completing the 
questionnaire, please write the number that corresponds to the box in which you have placed an X in 
the empty column to the right. Then, add the numbers and write the total in TOTAL box.  
 
From “AUDIT: The alcohol use disorders identification test: Guidelines for use in primary care, second edition” by Babor, T. F., 
Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G., 2001, Geneva, Switzerland, The World Health Organization. Copyright 2001 
by the World Health Organization. Reproduced with permission.
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 AUDIT Scoring 
Scores between 1 and 7:  
Your drinking has not reached a dangerous level. You may have a few drinks each week, and 
drinking may not have begun to cause trouble with other people in your life. If you have a score 
toward the high end of this range, you might want to start paying more attention to how much 
you are drinking, and how this may be affecting other people in your life.  
Scores between 8 and 20:  
You may be drinking every day, having blackouts, and feeling guilt or remorse after drinking 
Once you start drinking, it may be difficult for you to stop , and you may be having trouble 
following through on your responsibilities because of your drinking.  You may have even hurt 
someone in your life as a result of your drinking.  
Scores between 21 and 40:  
Your drinking has now reached a very dangerous level. Almost all the questions on the measure 
probably sound very familiar to you. There may be days when you cannot even get out of bed 
because of your drinking, and you may have trouble thinking about anything else. You may be 















From “AUDIT: The alcohol use disorders identification test: Guidelines for use in primary care, second edition” by Babor, T. F., 
Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G., 2001, Geneva, Switzerland, The World Health Organization. Copyright 2001 




Drug Use Questionnaire 
In the statements below, the term DRUG ABUSE refers to the use of drugs not including alcohol 
during the past 12 months. Carefully read each question and determine if your answer is YES or 
NO, then circle the appropriate response.  
1) Have you used drugs other than those required for medical reasons?  
  Yes   No     
   1   0     __________ 
2)  Do you abuse more than one drug at a time?  
  Yes   No 
  1   0     __________ 
3) Are you always able to stop using drugs when you want to?  
  Yes   No 
  0   1     __________ 
4) Have you had “blackouts” or “flashbacks” as a result of drug use?  
  Yes   No 
  1   0     __________ 
5) Do you ever feel bad or guilty about your drug use?  
  Yes   No 
  1   0     __________ 
6) Does your spouse (or parents) ever complain about your involvement with drugs?  
  Yes   No 
  1   0     ___________ 
7) Have you neglected your family because of your use of drugs?  
  Yes   No 
  1   0     ___________ 
8) Have you engage in illegal activities in order to obtain drugs?  
  Yes   No 
  1   0     ___________ 
9) Have you ever experienced withdrawal symptoms (felt sick) when you stopped taking 
drugs?  
  Yes   No 
  1   0     ___________ 
10) Have you had medical problems as a result of your drug use (e.g. memory loss, hepatitis, 
convulsions, bleeding, etc.)?  
  Yes   No 
  1   0     ____________ 
After completing the questionnaire, for each answer circled, write the corresponding number in 
the space provided next to the question. Then, add the number and write your total in the Total 
space.                     
TOTAL____________ 




Drug Use Questionnaire Scoring 
If you scored 0:  
You reported no drug related problems.  
If you scored 1-2:  
You have reported a low incidence of drug related problems; however, this does not necessarily 
mean that you are free of drug related problems. Consider the questions on which you endorsed 
drug related problems to determine what areas of your life are being affected by your drug use.  
If you scored 3-5:  
You have reported a moderate number of drug related problems. Your drug use is affecting 
several areas of your life. You will likely meet diagnostic criteria for a diagnosis of drug abuse. 
You may want to consider seeking treatment for your drug abuse.  
If you scored 6-8:  
You have reported a substantial number of drug related problems. You may want to consider 
seeking intensive treatment in order to change your current level of drug abuse.  
If you scored 9-10:  
You have reported a severe level of drug related problems that are likely impacting you in every 
area of your life. You may want to consider seeking intensive treatment in order to change your 

















Facilitator’s Adherence Checklist: Substance Abuse Session 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of AUDIT and DAST-10 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about substance abuse 
________________________________________________________________________ 
________________________________________________________________________ 







 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
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Measures included:  
Tobacco Use Stages of Change Measure 
Fagerström Test for Nicotine Dependence 










Tobacco Use Stages of Change Measure 
For the purpose of this measure, TOBACCO USE is defined as smoking cigars, cigarettes, 
and the use of smokeless tobacco.  
Please check the box that best fits your current tobacco use:  
1. I have not used tobacco for over 6 months.  
2. I have not used tobacco for less than 6 months. 
3. I am planning to quit using tobacco in the next 30 days.  
4. I am thinking about quitting using tobacco in the next 6 months.  
5. I am not thinking about quitting using tobacco.  
6. I have never used tobacco.  
Please circle your current stage of change corresponding to the number circled above.   
1. I have not used tobacco in a long time. I am using strategies to prevent relapse. I 
am in the MAINTENANCE stage.  
2. I have quit using tobacco. I am taking steps to avoid triggers and seek help from 
others.  I am in the ACTION stage.  
3. I am seriously considering quitting using tobacco.  I can see the benefits of 
quitting and have a plan to quit. I am in the PREPARATION stage.  
4. I am considering the possibility of quitting using tobacco, but remain unsure.  I 
may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my tobacco use is a problem. I am not thinking of quitting tobacco 
use. I am in the PRECONTEMPLATION stage.  




Fagerström Test for Nicotine Dependence 
 
Please circle the answer which best fits your current smoking habits.  
 
1. How soon after you wake up do you smoke your first cigarette? 
 a) After 60 minutes (0) 
 b) 31-60 minutes (1) 
 c) 6-30 minutes (2) 
 d) Within 5 minutes (3)       ______ 
 
2. Do you find it difficult to refrain from smoking in places where it is forbidden? 
 No (0)   Yes (1)                ______ 
 
3. Which cigarette would you hate most to give up? 
 a) The first in the morning (1) 
 b) Any other (0)        ______ 
 
4. How many cigarettes per day do you smoke? 
 a) 10 or less (0) 
 b) 11-20 (1)  
 c) 21-30 (2) 
 d) 31 or more (3)        ______ 
 
5. Do you smoke more frequently during the first hours after awakening than during the 
rest of the day? 
 No (0)   Yes (1)                   ______ 
 
6. Do you smoke even if you are so ill that you are in bed most of the day? 





After completing the questionnaire, for each answer circled write the corresponding 
number in the space provided next to the question. Then add the numbers and write 
your total in the Total space below. 
         TOTAL  ______ 
 
 
From “The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire” by Heatherton, T. F., 
Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O., 1991, British Journal of Addiction,86(9), 1119–1127. Copied with permission from 








Score Level of Dependence 
 
0-2 Very low dependence 
 
3-4 Low dependence 
 
 5  Medium dependence 
 
 6-7 High dependence 
 




Scores under 5:  
Your level of nicotine dependence is still low. If desired, you should act now to change 
your smoking habits before your level of dependence increases.  
Scores of 5:  
Your level of nicotine dependence is moderate. If you don’t quit soon, your level of 
dependence on nicotine will increase until you may be seriously addicted.  
Scores over 7:  
Your level of dependence is high. You aren’t in control of your smoking – it is in control 
of you. When you make the decision to quit, you may want to talk with your doctor 




From “The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire” by Heatherton, T. F., 
Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O., 1991, British Journal of Addiction,86(9), 1119–1127. Copied with permission from 




Facilitator’s Adherence Checklist: Tobacco Use Session 
 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of Fagerström Test for Nicotine Dependence 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about smoking 
________________________________________________________________________ 
________________________________________________________________________ 







 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
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Measures included:  
Aggression Stages of Change Measure 
Gun Safety Stages of Change Measure 
Aggressive Behavior Questionnaire 
Firearm Safety Questionnaire 





Aggression Stages of Change Measure 
For the purpose of this measure, AGGRESSIVE DRIVING is defined as verbal outbursts or 
physical gestures while driving; tailgating, cutting off, or chasing other drivers; driving 
under the influence; or intentionally driving your vehicle into another object.  
Please check the box that best fits your current driving behavior:  
1. I have not driven aggressively for over 6 months.  
2. I have not driven aggressively for less than 6 months. 
3. I plan stop driving aggressively in the next 30 days.  
4. I plan to stop driving aggressively in the next 6 months.  
5. I don’t think my aggressive driving is a problem.  
6. I do not drive.  
Please circle your current stage of change corresponding to the number circled above.   
1. I have not driven aggressively in a long time. I am in the MAINTENANCE stage.  
2. I have stopped driving aggressively. I am in the ACTION stage.  
3. I am seriously considering stopping  driving aggressively.  I can see the benefits 
of stopping and have a plan to stop. I am in the PREPARATION stage.  
4. I am considering the possibility of changing my aggressive driving, but remain 
unsure.  I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my aggressive driving is a problem. I am not thinking of stopping. I 
am in the PRECONTEMPLATION stage.  







For the purpose of this measure, AGGRESSIVE BEHAVIOR is defined as making verbal 
threats to others, assaulting others, engaging in acts of domestic violence, or 
intentionally damaging property.  
Please check the box that best fits your current aggressive behavior:  
1. I have not been behaving aggressively for over 6 months.  
2. I have not been behaving aggressively for less than 6 months. 
3. I plan to stop behaving aggressively in the next 30 days.  
4. I plan to stop behaving aggressively in the next 6 months.  
5. I don’t think my aggressive behavior is a problem.  
6. I have never behaved aggressively.  
Please circle your current stage of change corresponding to the number circled above.   
1. I have not been aggressive in a long time. I am using strategies to prevent 
aggression. I am in the MAINTENANCE stage.  
2. I have stopped being aggressive. I am taking steps to avoid triggers and seek help 
from others.  I am in the ACTION stage.  
3. I am seriously considering changing my aggressive behavior.  I can see the 
benefits of stopping and have a plan to stop. I am in the PREPARATION stage.  
4. I am considering the possibility of changing my aggressive behavior, but remain 
unsure.  I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my aggressive behavior is a problem. I am not thinking of changing. 
I am in the PRECONTEMPLATION stage.  
6. I have never behaved aggressively. The stages of change model is not applicable 





Gun Safety Stages of Change Measure 
For the purpose of this measure, GUN SAFETY is defined as always keeping your gun in a 
gun safe, lock box, or locked cabinet or drawer, always keeping your gun unloaded until 
it is ready to use, and always storing the bullets in a separate locked area.  
Please check the box that best fits your current gun safety behavior:  
1. I have implemented gun safety measures for over 6 months.  
2. I have implemented gun safety measures for less than 6 months. 
3. I plan to begin to implement gun safety measures in the next 30 days.  
4. I plan to begin to implement gun safety measures in the next 6 months.  
5. I don’t plan to begin to implement gun safety measures.  
6. I do not own a gun. 
 
Please circle your current stage of change corresponding to the number circled above.   
1. I have implemented gun safety measures for a long time. I am in the 
MAINTENANCE stage.  
2. I have implemented gun safety measures. I am in the ACTION stage.  
3. I am seriously considering implementing gun safety measures.  I can see the 
benefits of gun safety and have a plan to store my weapon/s safely. I am in the 
PREPARATION stage.  
4. I am considering the possibility of changing my gun safety behavior, but remain 
unsure.  I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not think my gun safety behavior is a problem. I am not thinking of changing. 
I am in the PRECONTEMPLATION stage.  




Aggressive Behavior Questionnaire 
For the purposes of this assessment measure, AGGRESSIVE BEHAVIOR is defined as: 1) making 
verbal threats to others, 2) assaulting others, 3) damaging property, and 4) aggressive driving.  
1) Have you made verbal threats to others?  
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
2) Have you assaulted others? 
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
3) Have you intentionally damaged property? 
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
4) Have you engaged in verbal outbursts or made angry hand gestures while driving? 
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
5) Have you tailgated, intentionally cut-off, or chased other drivers? 
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
6) Have you driven after drinking or taking psychoactive drugs? 
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
7) Have you intentionally driven your vehicle into another object (e.g. another car, tree, 
etc.)? 
a. Yes, in the last year. 
b. Yes, but over one year ago. 
c. No, I have never done so.  
8) In the past year, how frequently have you behaved in an aggressive manner (as defined 
above)?  
          Never              Sometimes   Very Regularly 
    0                1                  2                       3                     4                  5                   6 
 
 
From “The High-Risk Behavior Questionnaire” by Ruzek, J., Sherker, J., Dorian, E., Zeller, M., Huss, M., Drescher, K., et al., 2000. An 




Aggressive Behavior Questionnaire Scoring 
Question 1-3:  
Questions 1-3 refer to aggressive behavior including verbal threats, assault, and intentional 
damage of property.  These questions seek to look at the severity of aggressive acts as reflected 
by their recent occurrence.  
For those questions to which you chose to answer C, you do not appear to have difficulty with 
aggression in these areas.  
For those questions to which you answered B, you have had difficulty controlling your 
aggression in these areas in the past, but have taken steps to control your aggression and have 
not acted aggressively in a long time.  
For those questions to which you answered C, you have difficulty with aggression in these areas. 
At times your aggression is not under your control. You may need to seek help in order to learn 
to control your aggression.  
Question 4-7:  
Questions 4-7 refer to aggressive driving behavior. These questions increase in the severity of 
their level of aggression. Question 4 refers to the least aggressive driving behavior on this 
measure. The level of severity increases to Question 7, which reflects the most severe 
aggressive driving behavior measured here.  Please look at your answers at Questions 4-7 and 
note which behaviors you answered with A or B.  
For those questions to which you answered C, you have not been engaging in this type of 
aggressive driving.  
For those questions to which you answered B, you have been engaging in aggressive driving; 
however, you have been taking steps to curb your aggressive driving and have not engaged in 
aggressive driving for a long time.  
For those questions to which you answered C, you have been engaging in aggressive driving. At 
times, you aggressive driving is not under control. You may need to seek help to learn to control 
your aggression.  
Question 8:  
Veterans with PTSD are much more likely to engage in aggressive acts than veterans without 
PTSD or the general population. Please note how often you have behaved in an aggressive 
manner in the last year. The more frequently you have engaged in aggressive acts, the more 





Firearm Safety Questionnaire 
For the purposes of this questionnaire, FIREARM SAFETY is defined as: 1) keeping your 
firearm(s) unloaded, 2) keeping your firearm(s) in a locked safe, cabinet, or case, 3) 
keeping your firearm(s) protected with trigger, action or magazine locks, and 4) keeping  
bullets in a locked place, separate from the firearm(s).  
1) Do you keep all of your firearms in a safe manner (as defined above) whenever 
they are not actively in use?  (active use does not include having the gun out “for 
protection”) 
  Yes    No 
 
2) Have you kept all of your firearms in a safe manner when they are not in use for 
the past 6 months? 
  Yes    No 
 
3) Have your friends, family members, or mental health professional ever asked 
you to get rid of any or all of your firearms? 
  Yes    No 
 
4) In the past, have you ever considered suicide with a firearm? 
  Yes    No 
 
5) In the past, have you ever attempted suicide with a firearm? 
  Yes    No 
 
6) In the past, have you ever considered using a firearm to harm someone (not 
including during a military or law enforcement job)? 
  Yes    No 
 
7) In the past, have you ever fired a firearm at someone (not including during a 
military or law enforcement job)? 
  Yes    No 
From “The High-Risk Behavior Questionnaire” by Ruzek, J., Sherker, J., Dorian, E., Zeller, M., Huss, M., Drescher, K., et al., 2000. An 




Firearm Safety Questionnaire Scoring 
Question 1 & 2:  
 
If you answered YES to these questions, CONGRATULATIONS! You are keeping your guns 
in a safe manner and have been doing so for some time. You are promoting safe 
handling of weapons and decreasing the likelihood of a gun-related accident.  
 
If you answered NO to these questions, you may want to reevaluate your gun safety 
behaviors. Safe gun safety practices are recommended by the NRA as well as many 
other organizations to avoid unwanted injuries, damage, or death. In some states, 
improper gun safety may even be considered a crime.  
 
Question 3-7:  
 
Veterans with PTSD have been shown to be more likely to be aggressive and use 
substances, both situations in which the likelihood of a gun related accident are 
increased.  
 
Veterans with PTSD have also been shown to have high rates of depression. A serious 
symptom of depression may be suicidal thoughts. Most completed suicides happen 
among men with firearms.  When coupled with substance use, the risk of a completed 
suicide is even higher.   
 
Questions 3 through 7 refer to situations in which you may be at a higher risk of harming 
yourself or someone else with your firearm. If you checked YES  to any of these 
questions, it may be essential that you maintain good firearm safety practices or that 








Facilitator’s Adherence Checklist: Aggression and Gun Safety Session 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of Aggression and Gun Safety Behavior Questionnaires 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about aggression, aggressive driving, and gun safety 
________________________________________________________________________ 
________________________________________________________________________ 







 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
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Measures included:  
Sleep Hygiene Stages of Change Measure 
Sleep Questionnaire 
Health Risk Stages of Change Measure 
Health Behavior Frequency Measure 







Sleep Hygiene Stages of Change Measure  
For the purpose of this measure, SLEEP HYGEINE is defined as 1) establishing a sleep 
schedule, 2) avoiding caffeine, alcohol, and cigarettes before bedtime, 3) establishing an 
appropriate setting in which to sleep, and 4) using the bed and bedroom only for sleep 
and sex.  
Please check the box that best fits your current sleep hygiene:  
1. I have been practicing good sleep hygiene for over 6 months.  
2. I have been practicing good sleep hygiene for less than 6 months. 
3. I plan to begin to practice good sleep hygiene in the next 30 days.  
4. I plan to begin to practice good sleep hygiene in the next 6 months.  
5. I have no plans to practice good sleep hygiene.  
6. I do not have sleep difficulties.  
Please circle your current stage of change corresponding to the number circled above.   
1. I have been practicing good sleep hygiene for a long time. I am using strategies 
to continue this behavior. I am in the MAINTENANCE stage.  
2. I have been practicing good sleep hygiene. I am taking steps to avoid pitfalls or 
obstacles to poor sleep hygiene.  I am in the ACTION stage.  
3. I am seriously considering changing my sleep behavior.  I can see the benefits of 
good sleep hygiene and have a plan to start. I am in the PREPARATION stage.  
4. I am considering the possibility of changing my sleep behavior, but remain 
unsure.  I may be trying small changes. I am in the CONTEMPLATION stage.  
5. I do not want to change my sleep behavior. I am in the PRECONTEMPLATION 
stage.  
6. I have do not have sleep difficulties. The stages of change model is not applicable 




Sleep Questionnaire  
 
1) Do you have difficulty sleeping? Please check all boxes that apply. 
 Difficulty falling asleep   Frequent nighttime awakenings 
 Inadequate amount of sleep  Poor sleep quality 
 
2) Do you experience excessive daytime sleepiness? 
 Yes    No 
 
3) How often do you experience sleep difficulties? (e.g. every night, once a month)__________ 
 
4) Do you experience: 
 Frequent nightmares   Frequent body or limb movement during sleep  
 Panic-like awakenings    Fears related to sleep (e.g. nightmares, dark) 
 
5) Please check all that apply: Within 4 hours of bedtime, I…   
 Drink beverages containing alcohol    Eat 
 Drink beverages containing caffeine     Smoke   
 Use stimulant drugs 
 
6) Please check all that apply: In general, I… 
 Get limited exercise     Watch television or work in bed 
 Find my mind races or worries in bed   Take frequent daytime naps  










Sleep Questionnaire Scoring 
Question 1-3: 
If you experience any of these symptoms on a regular basis, have done so for at least one 
month, and if they impact your daily functioning, you may be experiencing sleep disturbances. 
Sleep disturbances can be caused by a variety of different things such as a problem with your 
sleep-wake cycle, a general medical condition, anxiety or depression, or substance use. If you 
are experiencing sleep difficulties, you may want to have a thorough sleep evaluation.  
Question 4:  
These sleep disturbances are commonly experienced by veterans with PTSD and have been 
shown to be related to the PTSD diagnosis. If you checked any of these boxes, your sleep 
disturbance may be related to your trauma experience.   
Question 5 & 6:  
Many sleep difficulties can be remedied by practicing good sleep hygiene. If you checked any of 
these boxes, your sleep habits may be contributing to your difficulty sleeping. You may want to 
consider changing your sleep related behavior in order to create an environment that supports 
healthy sleep. You may want to consider seeing a psychologist who can help you create a 




Health Risk Stages of Change Measure 
You have successfully completed the Live Long and Prosper group.  You have learned 
about health risk behaviors that are particularly relevant to veterans with PTSD, 
increased your awareness of your own engagement in health-risk behaviors, and 
reflected on your own willingness or need to change you behavior.  
Please take a moment to consider any current behavior in which you engage that may 
have a negative impact on your health. In particular, take time to reflect on the 
following: your diet, level of engagement in exercise, sleep problems, substance use, 
smoking, unsafe sex practices, level of aggression, and gun safety.   
 
Please circle the number that best fits your current health related behavior:  
1.   I have been engaging in behavior that has positive health impacts regularly for over 6 
months.  
 
2.   I have been engaging in behavior that has positive health impacts for less than 6 
months.  
 
3.   I plan to begin to engage in behavior that has positive health impacts in the next 30 
days.   
 
4.   I plan to begin to engage in behavior that has positive health impacts in the next 6 
months.  
 
5.   I have no plans to begin engaging in behaviors that have positive health impacts.  
 













Please circle your current stage of change that corresponds to the the number circled 
above.   
1.   I have been engaging in behavior that has positive health impacts regularly for a long 
time. I am using strategies to continue this behavior. I am in the MAINTENANCE stage.  
2.   I have been engaging in behavior that has positive health impacts. I am taking steps 
to avoid pitfalls or obstacles to my engagement in these positive behaviors.  I am in the 
ACTION stage.  
3.   I am seriously considering beginning to engage in behavior that has positive health 
impacts.  I can see the benefits these behaviors and have a plan to start. I am in the 
PREPARATION stage.  
4.   I am considering the possibility of engaging in behaviors that have positive health 
impacts, but remain unsure.  I may be trying small changes. I am in the 
CONTEMPLATION stage.  
5.   I do not want to change my behavior to engage in those with positive health 
impacts. I am in the PRECONTEMPLATION stage.  
6.   I have always engaged in behavior that has positive health impacts. The stages of 





Health Behavior Frequency Measure 
This measure is designed to help determine your current engagement in a variety of 
different behaviors that can impact on your health. Please circle the response that best 
fits your current level of engagement in these behaviors. Please be as honest as 
possible.  
1) How often do you incorporate these foods into your diet? Please circle the response that 
best describes your diet.  





















(e.g. chicken or fish 







Whole Grains  









2) How often do you engage in: 
a) Light intensity activities (e.g. casual walking, taking out the trash) per week? 
    Never    1 time  2 times  3 times  4 times   5 or more 
                
b) Moderate intensity activities (e.g. brisk walking) per week?  
    Never    1 time  2 times  3 times  4 times   5 or more
               
c) Vigorous intensity activities (e.g. jogging, swimming laps) per week?  
    Never    1 time  2 times  3 times  4 times   5 or more 
                
d) Strengthening activities (e.g. sit-ups, weight lifting) per week?  
    Never    1 time  2 times  3 times  4 times   5 or more 





3) Do you have difficulty falling or staying asleep?  
    Yes    No 
4) On average, how many hours of sleep do you get each night? _______________ 
5) Have you ever been tested for HIV or Hepatitis C?  
    Yes    No 
6) Have you engaged in unprotected sex (i.e. oral, anal, or vaginal sex without a condom)?  
                Yes    No 
7) If so, how frequently do you engage in unprotected sex?  
    Almost Never  Sometimes  Almost Always  Every time  
8) Have you made verbal threats to others?  
    Yes    No 
    If so, how often?  
   Rarely   Sometimes  Very Regularly 
9) Have you assaulted others?  
    Yes    No 
    If so, how often?  
 Rarely   Sometimes  Very Regularly 
10) Have you intentionally damaged property?  
    Yes    No 
   If so, how often?  
 Rarely   Sometimes  Very Regularly 
11) Have you engaged in aggressive driving (e.g. verbal outbursts, angry hand gestures, 
tailgating, driving under the influence, intentionally driving your vehicle into another object?)  
   Yes    No 
If so, how often?  
 Rarely   Sometimes  Very Regularly 




   Yes    No 
13) If you own a firearm, do you keep all of your firearms in a safe manner (e.g. unloaded, in a 
locked area with protected locks and the bullets separate from the firearms)? 
 Yes    No 
14) Do you drink alcohol?  
 Yes    No 
15) If you drink alcohol, how often do you have a drink?  
 Monthly or less     2-4 times a month  2-3 times a week        4 or more times a week  
 
16) On a typical day, how many drinks do you have?  
 1 or 2  3 or 4       5 or 6          7 to 9        10 or more 
 
17) How often do you have 6 or more drinks on one occasion?  
 Never        Less than monthly    Monthly Weekly  Daily or almost daily 
 
18) Have you used drugs other than those required for medical reasons (e.g. abuse of 
prescription medication or illegal drugs)?  
 Yes   No  
19) If you use drugs, how often do you use them?  
 Monthly or less      2-4 times a month  2-3 times a week       4 or more times a week 
 
20) Do you smoke cigarettes?  
 Yes    No 
21) How many cigarettes do you smoke per day?  
 10 or less 11-20     21-30      31 or more 
 
 






Facilitator’s Adherence Checklist: Sleep Session 
Please check off the following items that were covered in the session. Please note any items of 
relevance for each session component. In particular, if there were barriers to the completion of 
certain items, please note in the space provided the obstacles that presented a problem.  
 
 Administration of Stages of Change measures pre- and post- intervention 
________________________________________________________________________ 
________________________________________________________________________ 
 Review of group rules 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion of reactions from previous session 
________________________________________________________________________ 
________________________________________________________________________ 
 Introduction of session topic 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration/Discussion of Sleep Hygiene Questionnaire 
________________________________________________________________________ 
________________________________________________________________________ 
 Psychoeducation about sleep problems and sleep hygiene 
________________________________________________________________________ 
________________________________________________________________________ 







 Looking Forward exercise 
________________________________________________________________________ 
________________________________________________________________________ 
 Discussion/Ratings of Commitment/Confidence 
________________________________________________________________________ 
________________________________________________________________________ 
 Developing behavioral strategies 
________________________________________________________________________ 
________________________________________________________________________ 
 Administration of Health Risk Stages of Change and Health Risk Behavior Measures  
________________________________________________________________________ 
________________________________________________________________________ 
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